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SUMMARY
Elevated levels of reactive oxygen species (ROS) cause or aggravate a variety
of pathological conditions such as cardiovascular disease, cancer and rheumatoid arthri-
tis. Despite known links between oxidative stress and disease, years of clinical studies
have failed to show clear benefits of antioxidant therapy. It is now recognized that ROS
such as hydrogen peroxide can act as signaling molecules and are required for physio-
logical functioning of a number of signaling pathways. Therefore, a mechanistic basis of
ROS-mediated regulation of cell signaling must be established to enable rational design of
antioxidant-based therapies.
The challenges in quantification of transient changes mediated by ROS during cell sig-
naling have impeded investigation of redox-regulated signaling. In the present work, com-
putational modeling is used to circumvent these technical challenges and to test competing
hypotheses of redox regulation. Using a quantitative, systems level approach to study inter-
actions between ROS dependent and independent regulatory mechanisms, the most com-
prehensive model of the IL-4 signaling pathway to date has been developed and validated
with experimental data. The model is capable of predicting kinase phosphorylation dynam-
ics under new oxidative conditions, and our analyses suggest that reversible oxidation of
tyrosine phosphatases is the primary mechanism of redox regulation in this pathway. Addi-
tional computational methods have been developed to study ROS as mediators of crosstalk
between signaling pathways, to optimize model parameters, and to interrogate model dy-
namics for the purpose of model selection. Collectively, these modeling tools provide a
new systems-level perspective for investigating reversible protein oxidation as a means of




Even though it is recognized that reactive oxygen species (ROS) can regulate intracellular
signaling in both health and disease [23], the details of this regulation remain to be de-
termined. Binding of several types of extracellular ligands to their receptors can lead to
enzymatic production of ROS. A pertinent example is IL-4, a cytokine that transduces its
signal through the JAK/STAT pathway [130, 97]. The ability of ROS to influence the course
of cell signaling arises from their potential to oxidize thiol groups in cysteine residues of
proteins, leading to altered protein properties [62]. Several classes of proteins, including
kinases and phosphatases, have been identified as targets for reversible oxidation by ROS
with different sensitivities to oxidation [111]. Although several hypotheses are proposed
to explain ROS modulated signaling, their relative importance and systemic consequences
remain to be determined.
Technical limitations of experimental methods in reliably and sensitively measuring
ROS and their effects in cells have been an impediment in evolving a systemic framework
of redox signaling. Even though experimental methods for quantifying intracellular ROS
and oxidation of proteins are quickly developing, quantitative measurement of oxidative
changes in proteins remains a challenge [166, 104, 43]. The present work circumvents
these limitations of experimental techniques with the help of computational modeling based
on experimental data that can be reliably acquired, even though such data may not be
directly indicative of oxidative modifications of proteins. This work addresses the lack
of systems level understanding of redox signaling and helps establish principles of ROS-
mediated regulation of signal transduction.
1
1.1 Research objective and specific aims
The overall objective of this study is to develop a systems level understanding of ROS-
mediated regulatory mechanisms in signal transduction using the IL-4 pathway as a model
signaling system. The overarching hypothesis of this dissertation is that in the absence
of direct measurements on all redox regulatory mechanisms operating in IL-4 signaling,
computational modeling can be used to infer the importance of postulated mechanisms and
to discover the principles of redox regulation in the signaling pathway. Computational
modeling and experimental methods are used in synergy towards the following specific
aims.
Aim 1. Develop a systems model of redox regulation in the IL-4 signaling path-
way. The working hypothesis for this aim is that redox sensitivities at different points in a
signaling network produce non-identical effects, and interactions between redox sensitive
and redox independent mechanisms determine the systemic outcome. This hypothesis is
first tested using a computational model of the mitogen activated protein kinase (MAPK)
pathway with ROS dependent and independent regulatory mechanisms built into it [30].
Hypothetical scenarios with alternative regulatory mechanisms are explored using mathe-
matical models. The results suggest that the interplay of ROS dependent and independent
mechanisms is crucial in determining signaling dynamics (Chapter 2).
Computational modeling is next used to examine putative redox regulatory mechanisms
in the IL-4 pathway (Chapter 3). Time series data on feasibly measurable components
of the IL-4 signaling system have been acquired. The data are used to test alternative
models of redox regulation and the primary mode of redox regulation in the IL-4 pathway
is identified. The most comprehensive model of IL-4 signaling as yet has been developed
and validated as part of this aim.
Aim 2. Develop an optimization algorithm to estimate parameters of the IL-4
model. Since the model envisaged under aim 1 is novel by including mechanisms of reg-
ulation not studied before, a number of parameters of the model are not available in the
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literature. To estimate such parameters an optimization algorithm based on evolutionary
strategies (ES) has been designed and implemented. The purpose of this aim is to improve
the optimum searching capabilities of ES (Chapter 4). A variant of ES called ES-HM (ES
with hyper-mutation) has been developed to accomplish this aim, and the algorithm was
used to estimate the parameters of the IL-4 pathway model. This algorithm can be applied
more generally to other parameter estimation problems in systems biology models.
Aim 3. Study ROS mediated crosstalk of IL-4 pathway with other cytokine sig-
naling pathways. The working hypothesis for this aim is that the non-specificity of ROS
enables them to act as integrators of otherwise distinct signaling modules. Crosstalk be-
tween IL-4 and erythropoietin (Epo) pathways is studied using theoretical tools previously
developed to study degeneracy in biological networks represented by differential systems
[78]. The ability of ROS to integrate separate signaling modules is examined and functional
consequences of this potential function of ROS are discussed (Chapter 5).
1.2 Motivation and significance
Aerobic life forms require molecular oxygen (O2) as the ultimate electron acceptor in the
process of generating energy from nutrients. A side effect of mitochondrial respiration is
the low-level flux of reactive derivatives of O2 known as reactive oxygen species (ROS),
generated because the electron transport chain may allow “leakage” of electrons to oxygen
[146]. One electron reduction of O2 generates the superoxide anion radical (O−•2 ) which can
be converted to other forms of ROS through a series of reactions. Dismutation of superox-
ide, which may be spontaneous or catalyzed by superoxide dismutase (SOD) converts the
radical into O2 and hydrogen peroxide (H2O2). H2O2 is an uncharged molecule and is not a
highly active ROS. However, reaction of H2O2 with transition metal ions can generate the
hydroxyl radical (•OH), which is a very strong oxidizing agent [29]. Other reactive radical
and non-radical forms such as hydroperoxyl (HO•2) and hypochlorous acid (HOCl) may
also be generated. Uncontrolled levels of these oxidants can be toxic to the cell because
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of their reactivity with DNA, proteins, lipids and carbohydrates [23]. Antioxidant enzymes
like catalases, SODs and peroxidases have evolved to keep the toxic effects of ROS under
control.
Oxidative stress is defined as a condition in which ROS generation overwhelms the an-
tioxidant machinery of the cell and can lead to damage of cellular components. Oxidative
stress is known to be linked with a number of diseases including cancer, cardiovascular
diseases, rheumatoid arthritis and neurological disorders [114, 92, 160, 60]. Clearly estab-
lished association between oxidative stress and disease states, combined with some early
studies showing inverse relation between dietary consumption of antioxidants and heart
disease [37, 54] garnered support for the use of antioxidants as therapeutic agents with
potential to prevent or cure these diseases. However, to date, results from a number of
clinical studies using various types (e.g., vitamin E, vitamin C, β-carotene), combinations
and doses of antioxidants have not shown clear benefits in terms of primary or secondary
prevention of oxidative stress related diseases [92, 148, 12]. A small number of studies
have even found antioxidants to cause adverse effects in some groups of patients [71]. The
current status of antioxidant therapy is partly reflected in the American Heart Association’s
recommendation discouraging the use of antioxidant supplements for prevention of cardio-
vascular disease [71].
The lack of success of antioxidants seems surprising, considering that the connection
between oxidative stress and a number of diseases is well established; especially so, if
one were to look at ROS through a more traditional lens and perceive them as essentially
deleterious byproducts of aerobic respiration and other enzymatic and non-enzymatic pro-
cesses [36]. This picture of ROS, however, is no longer thought to be complete. The
NADPH oxidase (NOX) family of enzymes with specialized subcellular localization pat-
terns and activation mechanisms, serving the lone purpose of ROS generation, has come
to light [75]. Although other enzymes like xanthine oxidase and cyclooxygenase are also
known to produce ROS, it is not the primary function of these enzymes. For instance, the
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main function of xanthine oxidase is purine catabolism, while that of cyclooxygenase is
prostaglandin synthesis; ROS are only produced as byproducts of reactions catalyzed by
these enxymes [63]. Contrary to the incidental production of ROS by these enzymes or
by leakage through the respiratory chain, the superoxide anion radical, a form of ROS, is
the primary product of NOX enzymes. The existence of these enzymes specializing in the
production of ROS is unlikely to be a mere evolutionary accident.
Indeed, it is now well known that controlled enzymatic production of ROS is a feature of
many signaling pathways and ROS, such as hydrogen peroxide, act as signaling molecules
essential in determining the dynamics of these pathways [111, 115, 39]. Because of its
relatively mild reactivity, longer half-life and charge neutrality, H2O2 is considered to be
an important second messenger molecule [115]. Seen in this light, it is perhaps not so as-
tounding that untargeted use of general oxidant inhibitors should not yield specific benefits
in diseases. The clear role of oxidative stress in disease and the importance of ROS in
normal cell signaling are facts that need to be reconciled before antioxidant therapy can be
successfully utilized.
A major reason for the lack of understanding of redox signaling is the limitation placed
by experimental techniques available for measuring oxidative changes in proteins. While
new methods continue to be developed, currently available techniques are not absolutely
quantitative and are affected by many factors in unpredictable ways [64, 43]. Even if meth-
ods that could quantitatively measure temporal changes in protein oxidation were to be
available, the inherent complexity of signaling pathways would make it difficult to infer
how redox regulation is integrated into the rest of the pathway. Protein phosphorylation
serves as an illustration of this point – even though phosphorylation of many proteins in a
signaling pathway can be measured with good quantitative precision, the underlying regu-
latory mechanisms of the pathway are not obvious from the observables alone [124, 123].
Therefore, experimental insight must be complemented by other approaches like biologi-
cal systems modeling, that can help to discover design and operation principles and provide
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directions for future experimental work [38].
With this motivation, the present work is an effort towards developing the current un-
derstanding of the mechanisms by which ROS regulate cell signaling. Not only will this
clarify the role of ROS in physiological signaling, but will also shed light on how oxida-
tive stress contributes to disease. Furthermore, instead of qualitative generalizations that
classify ROS as more or less “evil” [115], or in the same vein, as a class of molecules
with split personalities of Dr. Jekyll and Mr. Hyde [39], a systemic and quantitative view
of the role of ROS in cell signaling is desirable. The term “systemic” is used here in the
sense that instead of focusing on individual components of a signaling pathway that could
be affected by ROS, a more holistic understanding should be sought wherein the emergent
effects of ROS mediated regulation of multiple redox-sensitive components and their inter-
actions with the rest of the signaling pathway are studied. Such a view, apart from being
descriptive and explanatory, could be predictive and enable design of rational intervention
strategies to prevent and cure oxidative stress related diseases. However, even though some
attention has recently been directed towards developing quantitative models of ROS gener-
ation and consumption in the cellular context [1], the understanding of the effects of ROS
on cell signaling remains qualitative in nature.
Mathematical modeling can be an extremely effective method to identify the underly-
ing principles of operation in biological systems [2]. Time series measurements of some
components of biological networks can be very useful for determining the underlying struc-
ture and parameters of the network [19, 149]. Inherent in the construction of mathematical
models is a quantitative description of the modeled biological processes. Additionally, by
appropriately choosing the levels of abstraction and detail to be incorporated in a model,
interactions between elements considered to be important and their emergent properties
can be studied. In the context of redox regulation in cell signaling, where some dynamic
changes such as protein phosphorylation can be reliably measured and others like protein
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oxidation cannot, mathematical modeling promises to be a very useful tool for understand-
ing the mechanistic basis of redox regulation.
Recognizing the need to understand the mechanisms by which ROS regulate cell sig-
naling and the importance of the integrative approach in studying complex biological phe-
nomena, the overall goal of the present work is to enhance a quantitative, systems level
understanding of redox regulation in cell signaling. Giving due consideration to the limita-
tions on the types of experimental data that can be reliably acquired as relates to redox reg-
ulated processes, mathematical and computational approaches are heavily relied on to fill
the gaps in knowledge left behind by intuitive interpretation of observables of the signaling
pathway. It is hypothesized that computational models informed by feasibly measurable
experimental data will be effective at filling these gaps and identifying the mechanisms of
redox regulation in signaling.
As an empirically observable phenomenon, the dependence of a variety of signaling
pathways on ROS has been established [137, 151, 88, 26]. With the assumption that there
must be some common principles of redox regulation applicable across a significant num-
ber, if not all, of these ROS sensitive pathways, the attention in this work has been focused
on select examples. In particular, the mitogen activated protein kinase (MAPK) cascade
and the IL-4 signaling pathway, with greater effort spent on the latter, were chosen. These
choices were driven by two determining factors: i) both these pathways have been shown to
depend on intracellular ROS [137, 130]; and, ii) the ROS-independent layers of regulation
in both these pathways are well characterized [98, 66]. While the first point is an absolute
requirement to study redox regulation of the pathways, the second is based on practical con-
siderations and is an attempt to minimize the number of unknowns. The presence of other
as yet undetermined regulatory mechanisms would only add confounding factors making it
difficult to isolate the effects of ROS on the signaling pathway. It should be noted that both
these pathways are typical examples of larger “families” of signaling pathways; whereas
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the MAPK cascade is commonly activated by growth factor and stress signaling [59], IL-
4 uses the JAK/STAT signaling pathway which is a common theme in cytokine signaling
[100]. Therefore, it is reasonable to expect that mechanisms found to be important in the
MAPK and IL-4 pathways will be applicable across a number of signaling systems.
The following sections cover the background pertinent to redox regulation of cell sig-
naling with focus on the IL-4 and MAPK pathways, and the biological and mathematical
points examined in the rest of this dissertation are highlighted.
1.3 ROS regulate protein function by cysteine modification
Activation of a variety of cell surface receptors including growth factor receptors [137, 99,
27], cytokine receptors [86, 159, 151, 136], hormone receptors [40, 88], B and T cell re-
ceptor [26, 73, 132] among others, causes increase in intracellular ROS. The production
of ROS following activation of signaling receptors is mediated by various enzymes of the
NADPH oxidase (NOX) family [17, 85, 95, 40, 122] . Seven members of the NOX family
(NOX1-5, DUOX1-2) are known[75]. The phagocytic NOX2 was the first NOX enzyme to
be discovered and is known to mediate the “respiratory burst” in phagocytes. It is a mul-
tisubunit enzyme made of the oxidase gp91phox and several cytosolic regulatory subunits.
Phosphorylation of the cytosolic units is required for the assembly of NOX2 [75]. NOX2
and NOX1 activation is also dependent on RacGTP [75, 18]. NOX5, DUOX1 and 2 on the
other hand, are dependent on Ca2+ for activation [76]. NOX assembly and disassembly are
complex process in themselves that are beyond the scope of this dissertation, but have been
previously studied using mathematical modeling [164, 165]. Studies cited above have also
shown that NOX mediated production of ROS in these signaling systems is functionally
important as perturbing normal ROS levels results in altered cell signaling behavior.
That ROS can affect cell signaling has been known for a long time with the discovery of
the ability of H2O2 to “mimick” the action of insulin [21]. Even before the components of
the insulin pathway were discovered, it was hypothesized that this effect must be mediated
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by oxidation of sulfhydryl functional groups on then unknown components of the pathway
[22]. The biochemical basis of ROS mediated regulation of cell signaling is a lot more clear
now and agrees in principle with this early hypothesis. It is now known that thiol (–SH,
also sulfhydryl) groups present in cysteine residues of proteins can be oxidized by ROS to
sulfenic acid form (–SOH) resulting in altered protein functions [166]. However, not all
cysteine thiols are susceptible to oxidation by physiological ROS. The local electrostatic
environment of some cysteine residues can lower their pKa from the typical value of more
than 8 to under 7. Such cysteines are ionized to the thiolate form (–S−) and are able react
readily with ROS to form protein sulfenic acid [158]. Further oxidation of the sulfenic
acid is possible generating the sulfinic acid (–SOOH) and subsequently the sulfonic acid (–
SOOOH) forms [158, 32]. Oxidation to the sulfinic and sulfonic acid forms is irreversible,
but the sulfenic acid can be reduced back to the thiol form by cellular oxidoreductase
enzymes like thioredoxin and glutaredoxin [10]. Mechanisms to protect the sulfenic acid
from further oxidation exist and the relatively unstable sulfenic acid is converted to intra-
or inter-molecular disulfide (or in some cases sulfenyl amide), protecting the cysteine from
further oxidation [141] (Fig. 1).
Based on the thiol chemistry described above, proteins with readily ionizable cysteines
can act as sensors of the cellular redox state. A diverse array of proteins such as transmem-
brane receptors like the epidermal growth factor receptor (EGFR) [104], kinases such as
ATM protein kinase [42], phosphatases like MAP kinase phosphatase 3 (MKP3) [127] and
the GTPase Ras [53], among others, have been shown to be sensitive to cysteine oxidation.
While oxidation of some proteins like MKP3 results in loss of catalytic function, in others
like EGFR, oxidation could enhance activity. This illustrates that utilizing the basic tem-
plate of cysteine oxidation allows ROS to influence the function of a diversity of proteins


































Figure 1: Thiol groups (-SH) of cysteine residues with low pKa are oxidized by physio-
logical ROS like hydrogen peroxide to form sulfenic acid (-SOH). The sulfenic acid form
may be protected from further oxidation by formation of intra- or inter-molecular disul-
fide bonds (-S–S-). Oxidoreductase enzymes glutaredoxin (Grx) or thioredoxin (Trx) can
reduce the oxidized cysteine restoring the protein to its original reduced state. GSH, glu-
tathione.
1.4 Redox sensitivity in the MAP kinase signaling pathway
MAP kinase cascade is a generalized term for a set of signaling pathways that possess
a similar three-tiered structure. These pathways are characterized by a phosphorylation
cascade in which a MAPK is activated through dual phosphorylation by MAPK kinase
(MAPKK), which in turn is activated following dual phosphorylation by MAPKK kinase
(MAPKKK) [109]. The pathways could be activated by a wide range of stimuli including
growth factors, hormones and stresses to activate different types of MAPK, and could reg-
ulate processes like proliferation, differentiation or apoptosis [59]. Platelet derived growth
factor (PDGF) is an activator of MAPK signaling and can activate the Raf/MEK/ERK cas-
cade [167]. PDGF signaling is also one of the first signaling pathways whose activation
was shown to be accompanied by heightened intracellular oxidation [137]. The specific ex-
ample of PDGF activated Raf/MEK/ERK pathway has been examined in this dissertation
to study redox regulation of this particular MAPK cascade.
The dephosphorylation of Raf/MEK/ERK pathway is regulated by a combination of
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serine/threonine phosphatases, dual specificity phosphatases (DUSP) as well as protein ty-
rosine phosphatases (PTPs) [109]. Members of all three phosphatase families, with known
roles in regulating the ERK signaling cascade, e.g. serine/threonine phosphatase PP2A
[34], tyrosine phosphatase SHP-2 [89], and dual specificity phosphatase DUSP3 [154] have
previously been shown to become inactivated by oxidation. It is likely that different phos-
phatases, especially those belonging to different families, have different rates of reactivity
with ROS [25]. Additionally, each phosphatase targets a different kinase in the MAPK path-
way. Different points of action of phosphatases combined with differential susceptibilities
to oxidation could have important roles in determining the dynamics of the ERK signal-
ing pathway. ROS independent processes, such as distribution of proteins across different
subcellular compartments or crosstalk between pathways, when overlaid with phosphatase
oxidation could affect system dynamics profoundly. These possibilities and their systemic
outcomes have been investigated in Chapter 2.
1.5 Diverse putative mechanisms of redox regulation in the IL-4 signal-
ing pathway
IL-4 is a pleiotropic cytokine with diverse roles in the immune system such as differentia-
tion of antigen-stimulated naive T cells into the TH2 type, immunoglobulin class switching
to IgE isotype in B cells and in regulation of allergy response [97]. IL-4 signals through the
IL-4 receptor α (IL-4Rα) and common γ chain (γC) complex. Receptor activation results in
phosphorylation and activation of receptor-bound Janus Kinase 1 (JAK1) and JAK3 which
then phosphorylate signal transducer and activator of transcription 6 (STAT6) [65]. Several
PTPs including PTP1B, TCPTP, CD45 and SHP-1 have been suggested to be important for
downregulation of IL-4 signaling [131].
The IL-4 pathway has been shown to activate NOX1 in the A549 cell line resulting
in upregulation of intracellular ROS, and perturbation of normal ROS production resulted
in altered STAT6 activation dynamics in these cells [130]. Three different mechanisms
that could potentially be involved in ROS mediated regulation of IL-4 signaling can be
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identified from a survey of the literature. The first of these mechanisms is reversible inac-
tivation of PTP activity by oxidation. Phosphatases of the PTP family carry a conserved
[I/V]HCXXGXXR[S/T] motif in the active site, and the invariant cysteine residue has an
unusually low pKa in the range of 4-6 [143, 103]. As described in Section 1.3, the low pKa
makes this cysteine highly susceptible to oxidation, and oxidation of the cysteine results in
inactivation of the PTP. The oxidation of cysteine thiol can be reversed by oxidoreductase
enzymes and the catalytic activity of the PTP restored (Fig. 1). Such cycles of ROS medi-
ated inactivation and subsequent reactivation of PTPs can modulate the dynamics of protein
phosphorylation. The second mechanism involves direct oxidation of receptor-associated
JAK molecules. Previously published research has shown that oxidation of JAK can re-
sult in loss of catalytic activity [133], which can directly affect the dynamics of processes
downstream of the JAK molecule. The third and final mechanism affects sub-cellular dis-
tribution of phosphatase activity. TCPTP, which is an important nuclear phosphatase of
STAT6 normally distributes evenly between the nuclear and cytosolic compartments; how-
ever, under conditions of oxidative stress it has a tendency to preferentially accumulate
in the cytosol [74]. Combined with the ability of STAT6 to shuttle between the nuclear
and cytosolic compartments, redistribution of phosphatase activity is likely to affect the
dynamics of STAT6 phosphorylation.
These three mechanisms, phosphatase oxidation, kinase oxidation and redistribution
of phosphatase activity across sub-cellular compartments, can affect signaling dynamics
in very distinct and profound ways. In Chapter 3 we investigate how the interaction of
these mechanisms with other redox-sensitive or insensitive mechanisms determines system
dynamics.
1.6 ROS mediated crosstalk and its consequences
An interesting feature of ROS mediated regulation of cell signaling is the relative non-
specificity of the action of ROS. Enzymatic control of signaling pathways through, for
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example, kinases and phosphatases has a great degree of specificity in the way an enzyme
chooses its target. The action of ROS on the other hand, instead of being protein specific,
is amino acid specific (see Section 1.3). This suggests that any protein accessible by ROS
and containing amino acid residues reactive towards ROS could potentially be modified,
irrespective of the source of ROS. In other words, ROS produced due to activation of one
signaling pathway could act as facilitators of pathway crosstalk and influence the dynamics
of another pathway. This type of crosstalk has indeed been observed before [94]. In relation
to the IL-4 pathway, it has been shown that ROS produced by activation of some other
cytokine signaling pathways can influence IL-4 signaling [130].
The potential of ROS to integrate otherwise distinct signaling modules has been given a
brief theoretical examination in Chapter 5. Li et al. have developed a mathematical formal-
ism to study functional integration (ROS mediated crosstalk in the present case) between
structurally distinct modules (the crosstalking pathways) in the context of biological sys-
tems represented by differential equation systems [78]. This formalism has been applied to
study ROS mediated crosstalk of IL-4 pathway with erythropoietin (Epo) signaling and its
implications have been discussed.
1.7 Estimation of parameters of the computational model
The system model of the IL-4 pathway presented in this dissertation incorporates several
novel regulatory mechanisms. The model parameters corresponding to these mechanisms
have neither been determined experimentally, nor have they been estimated in other mod-
eling studies. A variant of the evolutionary strategy ES algorithm [11] has been devel-
oped and utilized to estimate these unknown parameters. The algorithm is presented in
Chapter 4, and its performance is compared against other algorithms. Although developed
and applied as a tool to study the central question of redox regulation in cell signaling, this
algorithm is generally applicable to other problems in parameter optimization.
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CHAPTER II
SYSTEMIC REDOX REGULATION OF THE MAP KINASE
CASCADE 1
2.1 Introduction
With systems biology maturing as a discipline, it is natural that different approaches have
emerged to study the complexity of biological systems. One sub-discipline that has arisen is
known as cellular information processing. This approach borrows from engineering to treat
the cell as a “black box” with a number of extracellular inputs (e.g. soluble ligands, matrix
interactions) being interpreted, integrated and processed to elicit outputs (e.g. change in
phenotype, apoptosis, transcription). This sub-discipline generally focuses on small to
medium-sized network modeling to enrich understanding of regulatory mechanisms rather
than large genome-wide or proteome-wide data analysis. Redox regulation of the MAP
kinase cascade is studied here using this approach.
Oxidative modifications of protein thiols are emerging as important regulatory mech-
anisms, operating in combination with phosphorylation events to propagate signals. As
more proteins are identified as redox-sensitive, it becomes imperative to ask how thiol
oxidation within a signaling network modulates the interpretation of extracellular cues.
We constructed and analyzed computational models of common kinase/phosphatase motifs
in response to transient cellular oxidation in order to examine the systemic behavior that
emerges due to redox sensitivity of signaling proteins. While we focus on redox control in
the presence of hydrogen peroxide, the dynamic regulation of intracellular oxidants allow
the principles to extend to other reactive oxygen species.
1Modified from [30]
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2.2 Reversible oxidative inactivation of phosphatases
One of the most prevalent, conserved roles of protein thiol oxidation in signaling is the inac-
tivation of active-site cysteines across the protein tyrosine phosphatase (PTP) family [24].
Although the consequences on enzymatic function are uniformly inhibitory, the susceptibil-
ity of PTP isoforms to oxidation varies, as shown by both in vitro kinetic experiments [119]
and cellular studies [41, 105]. Furthermore, some serine/threonine phosphatases, such as
calcineurin [134] and PP2A [35] have cysteine thiols susceptible to oxidation while other
members of this protein family do not. Examination of signaling networks requires ac-
counting for the different degrees of inhibition of phosphatases during receptor-initiated
cellular oxidation.
We investigated general properties of systemic redox regulation through phosphatase
inactivation during dynamic cellular oxidation using a computational model that can ac-
count for previously published data [14]. Chao-Wei Chen et al. reported that PDGF stim-
ulation of human lens epithelial cells (HLE B3) activates the ERK signaling cascade with
concomitant production of hydrogen peroxide [14]. Catalase-mediated scavenging of hy-
drogen peroxide resulted in severely ablated ERK signaling. Furthermore, exogenous addi-
tion of H2O2 was sufficient to activate ERK signaling. We hypothesized that these observa-
tions can be explained by a model of ERK signaling that takes into account ROS-mediated,
reversible oxidative inactivation of phosphatases. The opposing activities of kinases and
phosphatases counterbalance each other in the basal state. When the cells are stimulated
with PDGF, the ERK pathway receives an upstream activating signal originating from the
receptor. Simultaneously, ROS-mediated inactivation of phosphatases skews the enzymatic
balance in favor of the kinases thereby activating the signaling cascade. Over time the input
signal decays and ROS production ceases, allowing the phosphatases to be reduced back
from their reversible inactive state. The signaling pathway is then restored to its basal state.
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Figure 2: Computational model of redox regulation in MAPK cascade. (a) ERK signaling
pathway with two step phosphorylation was modeled. Phosphatases were reversibly inhib-
ited by oxidation. Species highlighted in blue (RasGTP and ROS) were supplied as input
functions to the model. (b) Parameters of the model were optimized to fit experimental
measurements of MEK and ERK phosphorylation following PDGF stimulation of HLE B3
cells. The ROS input function (inset) was obtained by fitting a curve to measured DCF flu-
orescence. P3 was the most susceptible to oxidation and all of it got oxidized very quickly
and remained oxidized for the period of simulation. P2 had the slowest oxidation rate and
less than 1% of total P2 was oxidized throughout the simulation. P1 was maximally oxi-
dized at nearly 30 minutes with 16% of the protein in oxidized form which monotonically
decreased subsequently. (c) Catalase pretreatment was simulated using the model fitted
in b by setting ROS level to 0. The prediction was consistent with measured data. (d)
Exogenous bolus addition of H2O2 was simulated using the fitted model in b with an expo-
nentially decaying ROS curve (inset) and RasGTP was fixed at its basal level. Optimization
of the ROS curve alone was sufficient to fit the experimental data. ERKpp levels failed to
increase substantially if phosphatases P1 and P2 were assumed insensitive to oxidation. All
experimental data were obtained from [14].
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ROS mediated reversible inactivation of phosphatases (Fig. 2a). ROS dynamics were sim-
ulated using a curve fitted to PDGF induced H2O2 time course as measured in [14] (Fig. 2b
inset). A transient RasGTP signal was used an input to the model and was optimized to fit
the data. All three phosphatases (P1, P2, P3) were assumed to be susceptible to oxidation
but with varying sensitivities (Fig. 2a). The oxidation rates were optimized to fit experi-
mentally measured MEK and ERK phosphorylation time courses reported in [14] (Fig. 2b).
The variation in oxidation across the cascade may be representative of a) differences in
proximity to the ROS source and thus the effective concentration of H2O2; b) differences
in oxidation rates of the proteins; c) differences in reduction rates due to structural differ-
ences in oxidized proteins [15] or d) the specificity for a reducing enzyme (glutaredoxin
vs. thioredoxin). Although a prior modeling study demonstrated how inhibition of phos-
phatases is a means to influence MAPK dynamics through both duration and amplitude
of signal [56], the authors considered a flat rate of dephosphorylation for dynamic simu-
lations. Our added description of time-dependent variation in phosphatase activity due to
dynamic oxidative modifications provides regulatory features for fine-tuning the response
to a given input, depending on which phosphatases in a cascade are affected.
The model was able to reproduce experimentally measure ERK and MEK phosphory-
lation levels (Fig. 2b). Catalase pretreatment was simulated in the model by setting ROS
levels to zero at all times. The model predicted attenuated ERK phosphorylation in good
agreement with published data (Fig. 2c). An exogenous bolus addition of H2O2 was simu-
lated using a high initial value followed by a first order decay (Fig. 2d inset). Optimization
of two parameters, H2O2 initial value and decay rate, was enough to capture the experi-
mental observations. We note that the fit in Fig. 2b was obtained with very low oxidation
rates for P1 and P2 and a much higher rate for P3. Interestingly, the model suggests that
the slow oxidation could be physiologically important since making P1 and P2 completely
insensitive to oxidation resulted in no ERK phosphorylation even with exogenous addition
of a large amount of H2O2 (Fig. 2d).
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Figure 3: Topological features influence the contribution of phosphatases. Simulations
were performed by setting different combinations of phosphatases as redox sensitive. (a)
ERKpp levels when only a single phosphatase is redox sensitive. The same oxidation and
reduction rates were assigned to each phosphatase for consistency. Oxidation of phos-
phatases with substrates further removed from ERK leads to greater amplification of the
response. (b) ERKpp response when pairs of phosphatases are redox sensitive. The out-
put for two phosphatases appears to be a qualitative sum of the outputs when individual
phosphatases are redox sensitive.
This observation suggested that the location of P1 and P2 in the signaling network
may have an important role in their ability to influence the signaling. To test this idea we
performed computational experiments with the optimized model. Different sets of phos-
phatases were defined to be oxidation sensitive and dually-phosphorylated ERK (ERKpp)
was monitored as the output. The results suggest that phosphatases with substrates fur-
ther upstream of ERK are progressively more potent in influencing the signaling dynamics
(Fig. 3a). Furthermore, when pairs of phosphatases are redox sensitive, their individual
effects add up qualitatively (Fig. 3b). These results suggest that topologically conserved
MAPK networks can produce a variety of outputs, perhaps even to the same input signal,
as the dynamics of phosphatase oxidation/reduction change in a context-dependent manner.
2.3 Oxidative control through compartmentalization
Differences in redox potential in the cellular environment are created not only by punctate
distribution of ROS sources, but also by organellar compartmentalization [62]. The redox
















































Figure 4: Compartmentalization of redox potential affects signaling. (a) The model opti-
mized to HLE B3 cell data (Fig. 2) was modified to include nuclear-cytoplasmic shuttling
of ERK and its phosphatase P3. Nuclear entry and exit were modeled as first order reac-
tions with equal rate constants and were assumed to be the same for all proteins concerned.
(b) The nucleus was assumed to be at an identical oxidative state as the cytosol. Cytosolic
and nuclear levels of ERK were predicted to be similar. (c) The nucleus was modeled as
a more reduced compartment with no protein oxidation occurring in the nucleus. Protein
reduction rates were assumed to be the same in both compartments. Both the nuclear and
cytosolic signals are attenuated compared to panel b.
move across compartments. In particular, the nucleus has a more reducing microenviron-
ment than the cytosol by approximately a 20 mV difference in thioredoxin potential [46].
Oxidative modification can be reduced or enhanced by the transport process; consequently,
the dynamic location of a protein can impact its oxidation state and hence catalytic activity.
We modeled the impact of translocation of a redox sensitive protein from cytosol to a
relatively more reducing nucleus. MAP kinases can translocate to the nucleus to perform
their functions as transcription factor regulators. Phosphatases of MAPKs present in the
nucleus are exposed to a more reduced environment as compared to the cytosolic phos-
phatases and are hence likely to be more active. As a consequence, the cytosolic activity of
MAPK may not correspond exactly with the nuclear activity of MAPK. To assess the effects
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of compartmentalization of redox state between the cytosol and nucleus we used the opti-
mized ERK signaling model shown in Fig. 2 and extended it to include nucleo-cytoplasmic
shuttling of ERK and its phosphatase P3 (Fig. 4a). When the nucleus is assumed to be
at the same redox state as the cytosol with protein oxidation and reduction occurring at
the same rate in both compartments, the cytosolic and nuclear fractions of active MAPK
follow each other very closely (Fig. 4b). However, when the nucleus is taken to be more
reduced than the cytosol and free of ROS, then the nuclear fraction of active MAPK is sig-
nificantly attenuated (Fig. 4c). Moreover, the overall signal strength is also reduced by the
nuclear compartmentalization. Observations of ERK oscillations between the nucleus and
cytosol have an unexplained mechanistic basis in signaling regulation [128, 129, 152]. The
ability to regulate the active form of the kinase by redox regulation of its corresponding
phosphatase may be an explanation for the shuttling process.
2.4 Oxidative control through kinases
Unlike the phosphatases, the reported examples of other signaling molecules are much
more varied in the nature and consequences of their thiol modifications, ranging from af-
fecting enzymatic activity, cellular location or binding in macromolecular complexes. Re-
dox sensitivity of kinases can also profoundly influence cell signaling. There is recent
evidence that the MAPK p38 can be reversibly oxidized [142]. It was found that under
prostaglandin-stimulated oxidative conditions as well as with exogenous H2O2 addition,
phosphorylation of p38 is maintained while its activity is reversibly inhibited by oxidation
at multiple cysteine sites. To study this scenario we modified the model shown in Fig. 2
to include ROS mediated reversible oxidation of a dually phosphorylated MAPK (Fig. 5a).
In the absence of kinase oxidation, most of the dually phosphorylated MAPK is available
as free (i.e., unbound to other proteins) active MAPK, assuming that the dually phospho-
rylated form is the enzymatically active form (Fig. 5b). When the kinase is sensitive to




























Figure 5: Oxidative inhibition of MAPK. (a) Reversible oxidative inhibition of MAPK
was modeled by modifying the model in Fig. 2. The bis-phosphorylated form of MAPK
(MAPKpp) was assumed to be redox sensitive and the oxidation was reversible. (b) Taking
the MAPK cascade as corresponding to the p38 signaling pathway, simulations were per-
formed with dually phosphorylated p38 being sensitive to oxidation or not. Reduced dually
phosphorylated p38, unbound to other proteins was assumed to be the enzymatically active
form and the oxidized form was catalytically inactive. Inclusion of reversible oxidation
resulted in low p38 activity sustained over a longer period of time.
rest being in the oxidized state (Fig. 5b). These results agree qualitatively with the data
reported in [142]. In addition, the oxidation of phosphorylated MAPK serves as a seques-
tration mechanism for the active kinase. The oxidized form is reduced slowly back to the
active form allowing the active MAPK to be maintained at an almost steady, low level for
a longer period of time. This suggests that oxidation of the kinase may be a mechanism to
trap the rapidly generated active kinase and release it slowly over time.
2.5 Complexity in signaling networks
The relative contributions of different redox sensitive phosphatases can vary from those
seen in the linear kinase cascade in Figure 1, depending on the complexity of the system.
For example, heregulin (HRG) stimulation of ErbB receptor simultaneously activates the
Ras/Raf/MEK/ERK and PI3K/Akt pathways [52]. Apart from a common activating input,
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the two pathways are connected by two other links; i) cross-talk in the form of Raf inhibi-
tion by Akt ; and ii) a common serine/threonine phosphatase PP2A inhibiting the two path-
ways at Akt and MEK (Fig. 6a). As with PDGF, EGF receptor ligation has been reported
to induce reactive oxygen species as a necessary component of the signal transduction [27].
A computational model of this system was adopted from [52] and was modified to include
ROS mediated inactivation of phosphatases. This network presents the interesting feature
of ROS playing an activating, as well as inhibitory role in the ERK pathway at the same
time. ROS mediated inhibition of PP2A and MKP3 directly activates the ERK pathways.
However, inhibition of PP2A allows greater activity of Akt which inhibits ERK signaling
through Raf. Simulations show that with the same network structure, either of these effects
can dominate depending on parameters of the model. The presence of ROS could amplify
(Fig. 6b) or attenuate (Fig. 6c) ERK phosphorylation in a context dependent manner. This
suggests that increased complexity of the network makes it more difficult to predict the role
played by ROS in cell signaling. At the same time this shows that dynamic modification
of phosphatase activity affects the outcome of signaling in ways that are hard to predict in-
tuitively; therefore ignoring the dynamics of phosphatase modification in models of signal
transduction may not always be prudent.
2.6 Conclusion
These simple models are instructive in demonstrating that the degree of cellular oxida-
tion has the ability to modulate the amplitude and duration of signal transduction events
in biochemical signaling networks. Furthermore, compartmentalization of redox potential
in different cellular organelles can result in different interpretations of the same signaling
molecule due to subcellular location. Redox regulation is a powerful mechanism for tun-
ing the cellular response to a given input in a context-dependent manner; thus a cell may
skew towards a particular phenotype based upon the interpretation of a cue through altered


















































Figure 6: Increased complexity leads to variable effects of ROS regulation. (a) The Akt-
ERK crosstalk model was adopted from [52] and modified to include oxidative inhibition
of phosphatases MKP3 and PP2A. ROS production was assumed to be a NOX dependent
process requiring the presence of active PI3K and RasGTP for Nox activation. ROS pro-
duction was therefore modeled as a process driven by active PI3K and RasGTP and the
decay was a first order process. (b) Redox sensitivity of phosphatases resulted in ampli-
fication of ERKpp compared to a condition where no protein was redox sensitive. (c) By
strengthening the inhibitory effect of Akt on Raf, at the same time weakening the control
of PP2A on MEK dephosphorylation (altering three parameters in all) the qualitative effect
of ROS on ERKpp was reversed as compared to panel b. With the altered parameters the
oxidation sensitive model resulted in signal attenuation compared to the redox insensitive
model.
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be achieved without changing the topology of a signaling network.
Computational modeling of protein oxidation networks is a promising avenue for in-
terpreting the complex effects of cellular oxidation on cellular information processing. For
the model presented in Fig. 2, the addition of transient phosphatase activity was all that was
necessary in order to explain a number of experimental conditions in which altering redox
state affects signaling. While there are numerous aspects of redox signaling ignored in
these simulations (spatial gradients, mitochondrial vs. NOX mediated ROS production, ad-
ditional feedback mechanisms etc.), we can still gain insights into principles of regulatory
control by testing network topologies and differential sensitivities to reversible oxidation.
As knowledge builds of redox control mechanisms within signaling networks, it is likely
that common regulatory motifs will emerge across the varied receptor families in which ox-
idative bursts occur. A key question that improved proteomic tools [108, 112, 126] will help
answer is whether redox-sensitive proteins are evenly distributed within receptor signaling
networks, or clustered at specific nodes for influencing the relaying of information.
2.7 Methods
The model in Fig. 2 was derived from [124] by retaining only the three step Raf/MEK/ERK
module. To mimic the shape of RasGTP profile in [124], a skewed Gaussian curve was used
as RasGTP input. All parameters of the original model were used unchanged except initial
value of P2 which was increased 10 fold to fit the experimental data. The experimental
data were obtained from [14] and represent band intensities of Western blot experiments as
quantified in the original publication. The intensities were normalized to loading controls
for individual gels. The normalized ERKpp values were scaled and shifted so that the
lowest signal has a value of 0 and the signal at 15 minute is 1. The same scaling factor was
used for all experimental data in Fig. 2a and b. The scaled data for individual proteins were
shifted so that the lowest value in each set reads 0. The model outputs were scaled by the
computed value of ERKpp at 15 minute in Fig. 2a and b. Same method was used in Fig. 2d,
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however, the scaling to unity was for the 10 minute time point for both experimental and
model data. We used a curve fitted to experimentally measured H2O2 as ROS input to
the models in Fig. 2 (see Fig. 2b inset) which should account for all cellular sources of
ROS following receptor activation. The same input function was retained for models in
figures 1-4. Since no reliable method was available to scale DCF fluorescence intensities
to true H2O2 concentrations, we used DCF fluorescence values from Chen et al. [14] as a
scaled representation of the concentration. The protein oxidation and reduction rates were
defined in this context and do not represent true rates. The fitted phosphatase oxidation
rates spanned a wide range with orders of magnitude from 10−6 to 10. All proteins were
assigned the same reduction rate in Fig. 2. The reducing enzymes were assumed to remain
constant for the sake of parsimony and were not explicitly modeled. This model was used
as the basis for all models in figures 1-4 with appropriate modifications. Details of all
models are provided in Appendix A.
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CHAPTER III
COMPUTATIONAL MODELING PREDICTS PHOSPHATASE
OXIDATION AS THE PRIMARY MECHANISM OF REDOX
REGULATION IN IL-4 SIGNALING
3.1 Introduction
From initially being perceived as accidental and harmful byproducts of aerobic respiration,
reactive oxygen species (ROS) have now emerged as important regulators of physiological
cell signaling [32]. In particular, due its relatively milder reactivity and longer half-life,
H2O2 is recognized as an important second messenger in signal transduction [115]. Acti-
vation of several types of cell surface receptors induces transient ROS production by acti-
vating NADPH oxidase (NOX) family enzymes, and the ROS so produced play a role in
modulating downstream signaling [137, 27, 83]. ROS such as H2O2 react with the thiol
functional group of susceptible cysteine residues in redox sensitive proteins converting the
cysteine to sulfenic acid form [33]. While further oxidation is irreversible, the sulfenic acid
form can be protected by formation of disulfides and sulfenyl amides which can be reduced
back to the thiol form by oxidoreductases like thioredoxin and glutaredoxin [147, 121, 15].
This reversible cysteine oxidation can result in transient changes in protein function, such
as gain or loss of catalytic activity, at several levels in a signal pathway resulting in systemic
changes in cell signaling dynamics [30].
The IL-4 signaling pathway, which has important immunological roles like TH2 differ-
entiation and immunoglobulin E class switching [157], has been shown to be redox regu-
lated [130] and is controlled by a number of proteins which are potentially redox sensitive.
The pathway is initiated by binding of IL-4 to the IL-4 receptor (IL-4R) α chain and subse-
quent recruitment of the common gamma chain (γC) to form the type I receptor complex.
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A type II receptor complex is also formed in some cell types where the γC is substituted
by the IL-13Rα subunit [157, 97]. Jurkat T lymphoma cells, the cell line we have used
in our study, does not signal through the type II receptor and the following discussion is
limited to type I receptor [110]. Janus kinase (JAK) 1 and JAK3 are bound constitutively
to IL-4Rα and γC, respectively [65]. Formation of the receptor complex activates the JAK
molecules by trans-phosphorylation, which in turn phosphorylate several tyrosine residues
on the cytosolic tails of the receptor chains. The phosphorylated receptor recruits cytosolic
signal transducer and activator of transcription 6 (STAT6) which is phosphorylated by the
active JAK molecules. Phosphorylated STAT6 (pSTAT6) forms a homodimer, which is the
active form of STAT6 and can initiate transcription of target genes [157, 97]. A number
of protein tyrosine phosphatases (PTPs) are involved in downregulation of IL-4 signaling.
CD45 has been shown to inhibit phosphorylation of both JAK1 and JAK3 in response to
IL-4 stimulation [57, 162]. SHP-1 is another negative regulator of IL-4 signaling and it
binds an immunoreceptor tyrosine-based inhibitory motif (ITIM) in the cytoplasmic tail of
IL-4Rα, possibly dephosphorylating the receptor or JAK molecules [65, 49, 50]. PTP1B
and TCPTP dephosphorylate STAT6 and are involved in IL-4 signaling [80, 81]. The more
abundant 45 kDa form of TCPTP can shuttle between the cytosolic and nuclear compart-
ments making it an important nuclear regulator of STAT6 phosphorylation [80].
Multiple components of the IL-4 pathway described above can act as redox sensors.
Members of the PTP family are particularly sensitive to oxidation due to a low pKa cys-
teine residue in their active sites [106, 141, 103]. ROS such as H2O2 reversibly oxidize
several PTPs including PTP1B, TCPTP, CD45 and SHP-1 following activation of a vari-
ety of cell surface receptors or when ROS are added exogenously [88, 83, 117, 153, 15].
Along these lines, increased oxidation and inactivation of PTP1B was observed in IL-4
treated A549 cells [130]. It is very likely that the other PTPs involved in IL-4 regulation
are also redox regulated in a manner similar to PTP1B. In addition to the PTPs, members
of the JAK family have also been shown to possess a redox switch. JAK2 has been shown
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to become inactive under conditions of exogenous as well physiological oxidative stress
[133]. Structural homology between JAK1 and JAK2 [133] as well as indirect experimen-
tal evidence [72] suggest that JAK1 could also be inactivated by oxidation. Additionally,
JAK3 has been shown to be catalytically most active when highly reduced, with increasing
loss of activity with oxidation, independent of its phosphorylation state [28]. In addition to
catalytic activities of the PTP and JAK proteins, the subcellular localization of TCPTP has
also been shown to be affected by redox state of the cell with more oxidizing conditions
favoring cytosolic accumulation of TCPTP [74]. All these lines of evidence suggest that
IL-4 signaling could potentially be controlled by multiple mechanisms of redox regulation.
Along with redox sensitive control mechanisms, other equally important control sys-
tems are in place to ensure tight regulation of JAK/STAT signaling. A prior computational
study of the JAK2/STAT5 signaling system found that phosphorylation-state dependent
nuclear-cytosolic cycling of STAT5 was an important determinant of signaling dynamics
[139]. In the case of the IL-4 pathway, the mechanism of nuclear cycling appears to be
cell-type dependent. While there is evidence to indicate that STAT6 phosphorylation is re-
quired for nuclear translocation [4], the contrary has also been shown where STAT6 freely
shuttles between nuclear and cytosolic compartments [16]. Along with phosphatases, pro-
teasome dependent degradation and suppressor of cytokine signaling (SOCS) mediated
downregulation are also common motifs in JAK/STAT signaling [107, 20, 131]. Role of
proteasomal complexes in downregulating IL-4 induced STAT6 phosphorylation has been
previously reported [150, 49]. SOCS1 and SOCS3 proteins have also been found to inhibit
IL-4 signaling [79].
Given that multiple redox dependent and independent control points exist in the IL-4
signaling network, how do the various putative mechanisms interact to regulate signaling
dynamics? This question is particularly challenging because the outcomes of some of the
potential redox regulatory mechanisms are qualitatively opposite in nature. For instance,
while PTP oxidation could increase signaling activity, JAK oxidation could suppress it.
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Direct experimental measurements of protein oxidation changes during cell signaling are
essential to answer these questions. Methods for detecting intracellular changes in pro-
tein sulfenic acids are developing but technical challenges remain to be addressed before
quantitative, systems level measurements are possible [43]. Even if such data were to
be available, inferring relative contributions and interactions between various regulatory
mechanisms would not be straightforward due to the complexity of the signaling pathway.
Computational modeling is a powerful tool that can harness available data to uncover un-
derlying interactions in biological networks [68]. To answer the question posed above we
have used computational modeling informed by quantitative experimental data, both di-
rectly and indirectly related to redox processes, to study redox regulation in IL-4 signaling.
We conclude that PTP oxidation is the dominant mechanisms of redox regulation in IL-4
signaling and its interaction with redox independent mechanisms is critical in explaining
IL-4 signaling dynamics. We have developed a systems model of the IL-4 pathway that
successfully predicts IL-4 signaling dynamics over a wide range of redox conditions.
3.2 Methods
3.2.1 Cell culture and reagents
Jurkat T cells were cultured in complete media (RPMI-1640 containing 10% FBS, 1%
HEPES, 1% MEM non-essential amino acids, 1% sodium pyruvate, 100 U/ml penicillin,
and 100 g/ml streptomycin). For all experiments Jurkat cells were first serum starved at
a concentration of 2×106 cells/ml in media containing 0.5% FBS for 4 hours. The length
of serum starvation of selected to maximize observed change in STAT6 phospohrylation
(Section B.3). Human recombinant IL-4 (R&D Systems, Minneapolis, MN) was used at
100 ng/ml to treat the cells. The inhibitors cycloheximide (CHX), diphenyleneiodonium
chloride (DPI) and MG132 (all EMD Millipore, Billerica, MA) were administered at 20
µg/ml, 20 µM and 10 µM, respectively. Rabbit anti-STAT6 phosphotyrosine 641 antibody
(Cell Signaling Technology, Danvers, MA) was used at 1:100 dilution. Rabbit anti-SOCS3
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antibody (Abcam, Cambridge, MA) was used at 1:500 dilution. R-PE conjugated anti-
rabbit IgG (Life Technologies, Carlsbad, CA) was used as secondary antibody for flow
cytometry at 1:500 dilution. R-PE conjugated anti-STAT6 (BD, Franklin Lakes, NJ) was
used per manufacturer’s recommendation. CM-H2DCFDA (Life Technologies, Carlsbad,
CA) was used at 5 µM to measure intracellular oxidation.
3.2.2 Treatment with inhibitors and flow cytometry
Serum starved cells were suspended in PBS at 4×106 cells/ml. This cell density was chosen
to get maximal change in STAT6 phosphorylation with IL-4 treatment (Section B.3). For
each time point in an experiment, the appropriate inhibitor was added one hour before IL-4
stimulation. Cells were fixed in 1.5% paraformaldehyde for 10 min at room temperature
and permeabilized in 90% methanol for 30 min at 4◦C. After staining with suitable anti-
bodies, the samples were analyzed on a BD LSR II flow cytometer (BD, Franklin Lakes,
NJ). Fluorescence data were analyzed using in-house code written in Matlab; mean fluo-
rescence intensity (MFI) was used to summarize the behavior of analyzed cell populations.
For pSTAT6 and SOCS3 analysis, cells non-specifically labeled only with secondary anti-
body were used to acquire the background signal. For STAT6, unstained cells (because the
primary Ab was fluorophore conjugated) were used as background. To enable comparison
between experimental conditions, background corrected MFIs were normalized by divid-





where, MFInorm is the background corrected, normalized MFI, MFIsample is the experimen-
tally measured MFI of the sample, MFIbk denotes the background MFI and MFIuntreat is the
measured MFI of untreated Jurkat cells.
To detect intracellular redox state, CM-H2DCFDA was added 30 min prior to IL-4
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stimulation. After adding IL-4, samples were analyzed on BD LSR II Flow Cytometer to
measure CM-H2DCFDA MFI. MFI time course of CM-H2DCFDA stained cells not treated
with IL-4 was subtracted as background from all other CM-H2DCFDA time courses.
3.2.3 Computational modeling of the IL-4 pathway
All modeling, simulation and analysis was performed in Matlab. For Monte Carlo (MC)
simulations, all the networks to be analyzed were coded as ordinary differential equation
(ODE) systems assuming mass action kinetics and solved using numerical ODE solvers in
Matlab. The ODE system representing the largest model with all regulatory mechanisms
and the parameter bounds used for the MC simulations are shown in Appendix B.1. The
systems model of the IL-4 pathway was implemented using the Simbiology toolbox in
Matlab. Equations and parameters of the model are presented in Appendix B.2. Derivatives
of Hill curves fitted to experimentally measured CM-H2DCFDA fluorescence were taken
to represent instantaneous intracellular ROS trends. The time derivative of the fitted Hill
curve, f (x) was modified to a + b f (x), where a and b are model parameters representing
baseline ROS level and a scaling factor, respectively. The modified curve was supplied to
the model as an input. Simulated time course x(t) of species x was also similarly scaled to
y(t) = αx + βxx(t), where αx and βx are constants defined for species x and are independent
of experimental conditions. Different scaling is required for different species because the
antibody used to measure each protein has different characteristics and the measured MFI
scales differently to actual amount.
Initial estimates of parameters were obtained from [161] and [1]. Evolutionary strate-
gies with hyper mutation algorithm was then used (Chapter 4) to fit the model to experi-














where, yi j(t) is the scaled and shifted value (as described above) of the jth species un-
der the ith experimental condition at time t; ei j(t) represents the experimentally measured
value under the same circumstances and σi j(t) is the standard error associated with the
experimental measurement.
3.3 Results
3.3.1 ROS are necessary but not sufficient for STAT6 phosphorylation
Jurkat cells were stimulated with IL-4 and intracellular oxidation was monitored using flow
cytometry by staining the cells with CM-H2DCFDA. Fluorescence of the dye increased
quickly after addition of IL-4 and showed a tendency to saturate 1 hour after IL-4 addition
(Fig. 7a). Pretreating the cells with DPI, an inhibitor of phagocytic Nox and flavoprotein
inhibitor, lowered the baseline oxidation of the dye and significantly reduced oxidation
following stimulation with IL-4. Since the oxidation of CM-H2DCFDA is an irreversible
process, the fluorescence time courses shown in Fig. 7a represents cumulative oxidation of
the dye as a function of time. In order to infer instantaneous levels of ROS from the cu-
mulative dye oxidation time courses, Hill curves were fitted to the data points (Fig. 7a) and
derivatives of these curves were obtained (Fig. 7b). The derivatives indicate that following
IL-4 treatment of Jurkat cells, intracellular ROS concentration increased rapidly peaking at
approximately 20 min and gradually returned to baseline level. In DPI pretreated cells the
change in ROS level was observed to be much lower than that in untreated cells.
To study the effects of ROS on IL-4 signaling, time-dependent phosphorylation of to-
tal intracellular STAT6 (i.e, sum of nuclear and cytosolic pSTAT6, see Appendix B.4) was
quantified under a variety of oxidative conditions. Treatment of Jurkat cells with IL-4 sig-
nificantly increased STAT6 phosphorylation within 5 min and kept it elevated for 2 hours
(Fig. 7c). Cells pretreated with DPI showed significantly lower baseline phosphorylation
of STAT6 and responded very weakly to IL-4 stimulation. Addition of exogenous hydro-
gen peroxide (10 µM) in addition to IL-4 further increased STAT6 phosphorylation when
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Figure 7: IL-4 induced ROS is required for STAT6 signaling. (a) Jurkat cells were pre-
treated or not with 20 µM DPI for one hour and stimulated with 100 ng/ml IL-4. Cells were
incubated with 5 µM CM-H2DCFDA for 30 min before IL-4 addition. Fluorescence inten-
sity of oxidized dye was recorded for each time point using flow cytometry. The lines are
hill curves fitted to the means. (b) Derivatives of the Hill curves shown in a. (c) Jurkat cells
pretreated or not with 20 µM DPI for one hour were stimulated with 100 ng/ml IL-4 and
pSTAT6 was quantified using flow cytometry. (d) Jurkat cells were treated with H2O2 (10
µM), IL4 (100 ng/ml) or both and pSTAT6 was measured. Values on y-axis represent back-
ground subtracted and normalized mean fluorescence intensities. Graphs represent mean
± standard error of mean. n = 6 for pSTAT6 under IL4 stimulation for all but the 4th (15














Figure 8: pSTAT6 shows oscillatory behavior. Tukey’s HSD test was used for pairwise
comparison of pSTAT6 from Fig. 7c across time points. Comparison of pSTAT6 at 0 min
(blue bar) with all other time points is shown. The bars represent comparison intervals
according to Tukey’s HSD and non-overlapping intervals indicate significant difference at
p = 0.05 level. Red bars, significantly different from pSTAT6 at 0 min; gray bars, not
significantly different. X-axis is not to scale.
compared to IL-4 treatment alone (Fig. 7d). However, addition of the same concentration
of H2O2 in the absence of IL-4 failed to alter STAT6 phosphorylation from its basal level.
3.3.2 Interplay of PTP oxidation with nuclear-cytosolic shuttling of proteins results
in characteristic phosphorylation dynamics
The pSTAT6 time course in response to IL-4 stimulation of Jurkat cells shows oscillatory
behavior attaining two local maxima over the two hour period (Fig. 7c). Statistical signifi-
cance of differences in STAT6 phosphorylation between time points was tested using a one
way ANOVA. STAT6 phosphorylation differed significantly across time points with F(8,
39) = 3.71, p = 0.0026. Tukey-post hoc comparison across the time points indicated that
at p = 0.05 level, pSTAT6 at 0 min was significantly lower than pSTAT6 at all other time
points except the 25 min and 120 minute time points (Fig. 8). This implies that the first
peak of pSTAT6 occurs between 0 and 25 min and the second one between 25 and 120
min.
We hypothesized that the dynamic information contained in the STAT6 phosphoryla-
tion time course, especially the characteristic shape of the oscillating curve, could be used
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to infer the regulatory mechanisms involved in IL-4 signaling. We sought to use this in-
formation to investigate the importance of 4 distinct regulatory mechanisms described in
Section 3.1: i) reversible inactivation of PTPs by oxidation; ii) ROS mediated cytosolic ac-
cumulation of PTPs; iii) reversible inactivation of JAK by oxidation; and iv) dependence of
nuclear-cytosolic shuttling of STAT6 on its phosphorylation state. While the first three are
directly influenced by redox state of the cell, the fourth is not. To investigate the systemic
effects of these mechanisms, we constructed a library of models of IL-4 signaling to rep-
resent various combinations of these four regulatory mechanisms. Next, we assessed these
models based on their ability to produce an oscillating curve with characteristics similar to
those seen in the experimental data. The details of this process are described below.
The IL-4 signaling network was divided into 5 regulatory modules and by taking differ-
ent combinations of these modules, a library of 16 different models was constructed (details
in Fig. 9). This library covers all possible combinations of the 4 mechanisms listed above.
Next, simplified ODE representation of all 16 models were obtained using a rationale based
approach to reduce model complexity. Specifically, linear chains of events such as sequen-
tial assembly of active receptor complex, or dimerization of phosphorylated STAT6 were
collapsed into a single reaction. JAKs, which are constitutively bound to the receptor, were
not modeled explicitly and were assumed to be implicit in the receptor. Different PTPs that
can act on STAT6 were abstracted as a single generic PTP. The various network topologies
obtained were coded into systems of ordinary differential equations assuming elementary
mass action kinetics for all reactions. Parameters of the models were manually adjusted so
that total pSTAT6 dynamics roughly matched the experimentally observed dynamics. For
each model, 50,000 sets of parameters were randomly sampled in a fixed space spanning
one order of magnitude around the estimated parameter vector, the model was simulated for
all sampled parameter vectors and the dynamics of total pSTAT6 (i.e., nuclear and cytosolic
pSTAT6) were recorded. The predicted pSTAT6 traces were qualitatively and quantitatively
compared with the experimental results as described next to judge the fitness of the models.
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Figure 9: Creating a library of models of IL-4 signaling. Four regulatory modules were
constructed around the core of IL-4 initiated STAT6 signaling. The core module (blue box)
comprises IL-4 induced receptor (R) activation and subsequent STAT activation. Activated
receptor upregulates ROS which can affect signaling through three different modules: re-
versible phosphatase (P) oxidation (red box), reversible JAK (assumed to be implicit in the
receptor) oxidation (green box), or by modulating nuclear-cytosolic shuttling of the phos-
phatase (purple box). The last module (yellow box) relates to nuclear-cytosolic transloca-
tion of STAT6. This module represents two possible variations: i) the dashed arrows are
absent and STAT6 trafficking is unidirectional and dependent on its phosphorylation state;
ii) the dashed arrow are present and STAT6 translocation is independent of its phospho-
rylation state. Keeping the blue module in place, the red, green and purple modules were
added or not and the dashed arrow in the yellow module were included or not. This results
in a total of 16 different models representing all possible combinations of the 4 regulatory
modules.
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The models were first tested qualitatively based on their ability to reproduce the oscil-
latory behavior observed in the experimental data. This was done by counting the number
of local maxima in each pSTAT6 trace produced by the models. All simulations produced
two or fewer peaks, and traces that could produce exactly two distinct local maxima were
taken to qualitatively match the oscillations observed in the experimental data. Among the
16 models, 7 failed to produce any oscillating traces for total pSTAT6. Of the remaining
9 models which generated one or more oscillating traces, 5 models produced fewer than
50 instances (0.1% of total number of MC simulations) of oscillating pSTAT6 (Fig. 10).
Using this threshold of 0.1%, 12 configurations were rejected as likely models on a purely
qualitative basis. Notably, all the 8 models in which STAT6 translocation was independent
of its phosphorylation state consistently produced none or extremely small numbers of os-
cillating pSTAT6 traces. This strongly suggests that cycling of STAT6 between nucleus and
cytosol is phosphorylation dependent. Only 4 models demonstrated the occurrence of two
distinct peaks for more than 0.1% of the 50,000 MC simulations (Fig. 10). All 4 of these
models included PTP oxidation as a redox regulatory mechanism. The model that had PTP
oxidation as the only ROS mediated mechanism (first bar in Fig. 10) generated the most
instances of oscillating pSTAT6 traces. The other two redox regulated mechanism, JAK
oxidation and ROS mediated nuclear translocation of PTP, could not cross the 0.1% thresh-
old when acting alone; however, combining one or both of these mechanisms with PTP
oxidation allowed oscillation to occur. Nevertheless, fewer instances of oscillating traces
were generated when either one of these mechanisms was combined with PTP oxidation,
and even fewer when both were added in together (Fig. 10).
Quantitative comparison of features of the oscillating curves generated from the simu-
lations with the experimental data provides further support to PTP oxidation as the prime
mechanism of redox regulation in IL-4 signaling. A smoothing spline was fitted to the
mean pSTAT6 data and features of the curve including heights of the two peaks, separation


















Figure 10: Models that reproduce oscillating pSTAT6 dynamics. For each model 50,000
MC simulations were run and dynamics of total phosphorylated STAT6 were analyzed.
Counts of simulations that produced oscillatory pSTAT6 dynamics are shown. The dot ma-
trix under the x-axis indicates the regulatory mechanisms included in each model. Dots
in the first three rows mark inclusion of the following redox regulatory mechanisms: row
1, PTP oxidation (red module in Fig. 9); row 2, ROS mediated PTP translocation (purple
module in Fig. 9); row 3, JAK oxidation (green module in Fig. 9). A dot in the fourth row
means STAT6 cycling between nucleus and cytosol was dependent on its phosphorylation
state (dashed arrows excluded from the yellow module in Fig. 9), whereas a blank means
that cycling was phosphorylation independent (dashed arrow included in the yellow mod-
ule). Bars below the dashed line correspond to models for which under 0.1% of all MC
simulations produced oscillatory behavior.
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that produced two distinct local maxima for the total pSTAT6 trace were identified for each
model. The features indicated in Fig. 11a, were extracted from the simulated curves. Ratio
of peak heights, separation between the peaks and ratio of final value to first peak were
computed and compared with the experimental results. Representative results are shown
for two models in Fig. 11(b, c, d and e). When only PTP oxidation was included as a
mechanism of redox regulation, not only did the model produce most instances of oscillat-
ing curves, but the shapes of these curves also conformed well with the measured dynamics
(Fig. 11b and d). However, when other ROS dependent mechanisms were added on to the
model, both the number of oscillating curves and their similarity with experimental data
worsened (Fig. 11c and e). Similar results were obtained when PTP oxidation model was
compared with any other model.
Taken together, these results provided very strong support to two of the four regulatory
mechanisms considered and we concluded that i) PTP oxidation is the most important mode
of redox regulation in IL-4 signaling; and ii) nuclear-cytosolic translocation of STAT6 is
phosphorylation dependent.
3.3.3 Inhibition of protein synthesis or protein degradation amplifies STAT6 phos-
phorylation
Jurkat cells pretreated with cycloheximide (CHX), an inhibitor of protein synthesis, were
stimulated with IL-4 and time course of STAT6 phosphorylation was acquired. Phospho-
rylated STAT6 increased significantly within five minutes of IL-4 stimulation and then
decreased steadily for 2 hours (Fig. 12a). Furthermore, the average phosphorylation of
STAT6 was higher in CHX pretreated cells as compared to untreated cells. Pretreating the
Jurkat cells with MG132, an inhibitor of 26S proteasome complex, prior to IL-4 stimulation
also increased mean STAT6 phosphorylation compared to cells not pretreated with MG132
(Fig. 12a).
SOCS1 and SOCS3 have been shown to be downregulate IL-4 signaling [79]. We
measured SOCS3 time course in response to IL-4 stimulation in order to elucidate the
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Figure 11: Inferring regulatory mechanisms using Monte Carlo simulations. (a) A
smoothing spline (continuous line) was fitted to mean pSTAT6 time course, shown by dots,
under IL-4 stimulation and distinguishing features of the curve were extracted. (b, c) Ratio
of final value to height of peak 1 (left axis and squares) and time separation between peaks
(right axis and stars) are plotted against the ratio of peak heights. Data points indicated by
red markers show points corresponding to the fitted spline in a. (d, e) Models correspond-
ing to simulation results in b and c, respectively. Simulation results overlap better with
experimental results in b than in c; this was confirmed by numerical calculation of average












































































Figure 12: Mechanisms of downregulation in IL-4 signaling. (a) Jurkat cells were pre-
treated with 10 µM MG132, 20 µg/ml CHX or PBS (mock inhibitor) for 1 hour prior to
stimulation with 100 ng/ml IL-4. pSTAT6 was measured. (b) SOCS3 was quantified in
cells pretreated for 1 hour with cycloheximide (CHX) or PBS and stimulated with IL-4.
(c) Total STAT6 was measured in Jurkat cells left untreated or treated with IL-4. (d) Jurkat
cells were pretreated with MG132 and total STAT6 was measured with or without IL-4
stimulation. y-axis shows background subtracted normalized MFI values obtained using
flow cytometry; all plots show mean ± standard error based on n = 3; au, arbitrary units.
pSTAT6 amplifying effect of CHX. SOCS3 expression in IL-4 treated Jurkat cells decreased
from its baseline level over two hours (Fig. 12b). In cells pretreated with CHX, the basal
expression of SOCS3 was reduced and did not change significantly over two hours. This
suggests that inhibition of protein synthesis by CHX lowered the basal concentration of
SOCS3, and the reduced SOCS3 expression weakened the downregulating signal present
at time 0 to allow a larger response to IL-4 at a very early time point (Fig. 12a).
To assess the effect of MG132 on STAT6 levels in Jurkat cells, we quantified total
STAT6 in cells stimulated with IL-4 with or without MG132 pretreatment. In the ab-
sence of any treatment, total STAT6 expression decreased over time. Stimulation with IL-4
slowed down the decrease in STAT6 (Fig. 12c). Pretreatment with MG132 lowered the av-
erage expression of STAT6 slightly and stopped the decay of STAT6 over time. Addition
of IL-4 to MG132 pretreated cells resulted in further elevation of total STAT6 level over
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time (Fig. 12d). These results suggest that proteasome mediated degradation of STAT6
acts as a mechanism to downregulate IL-4 signaling. Furthermore, IL-4 treatment elevates
total STAT6 levels, whether or not the cells are exposed to MG132. This indicates that
phosphorylation following IL-4 stimulation may be protecting STAT6 from proteasomal
degradation.
3.3.4 A systems model of ROS mediated regulation of IL4 signaling
The experimental results presented above taken together with the results from the MC sim-
ulations suggest a complex picture of the IL-4 pathway with many regulatory mechanisms
operating in tandem. We constructed an ordinary differential equation model of the IL-4
signaling pathway using mass action kinetics that incorporates these important regulatory
mechanisms and explains the observed dynamics of various molecular species under a va-
riety of experimental conditions. A graphical representation of the model is shown in
Fig. 13. Mechanisms found to be most important from the MC analysis were built into the
model. Experimental results on downregulation mechanisms were used to include SOCS
and STAT6 degradation as important control mechanisms.
In the interest of parsimony several simplifying assumptions were made in the model.
The IL-4 receptor alpha chain and the common gamma chain were not modeled separately.
Instead, an abstraction of the receptor complex in the form of a single transmembrane
molecule that binds IL-4 and gets activated was used. The JAK1 and JAK3 molecules
that are constitutively bound to the receptor chains were also not modeled explicitly and
were assumed to be implicit in the receptor molecule. SOCS family proteins have been
shown to inhibit JAK/STAT signaling by binding directly to phosphorylated JAK molecules
inhibiting their function, or by binding to the receptors and indirectly inhibiting JAK [9].
Since JAK and receptor molecules were abstracted into a single species, SOCS binding
to activated receptor was taken to represent both possibilities. Dephosphorylation of the
receptor complex was assumed to result in dissociation with SOCS. SOCS1 and SOCS3
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are known to affect IL-4 signaling and were modeled together as a generic SOCS molecule.
Multiple phosphatases including PTP1B and TCPTP have been shown to act on STAT6
[80, 81]. Similarly, multiple phosphatases, such as CD45 and SHP-1, can dephosphorylate
the receptor and JAK molecules [57, 65]. We assumed that STAT6 and the receptor complex
were dephosphorylated by distinct individual PTPs. All reaction were modeled using the
law of mass action except active STAT6 mediated SOCS production ; the rate of production
of SOCS was assumed to increase monotonically with the concentration of active STAT6
in a saturating fashion to model saturation of transcription factor binding sites.
Activation of the IL-4 receptor in Jurkat cells induced transient production of ROS
(Fig. 7b). ROS dynamics estimated from experimental data were used as an input to the
model, thus eliminating the need to explicitly model the sources and mechanisms of ROS
production and elimination. Reduction of oxidized proteins was assumed to follow first
order kinetics; in other words, the reducing capacity of the cell was assumed to be con-
stant over time. The more reducing environment of the nucleus [67, 82] was modeled by
eliminating any protein oxidation from the nuclear compartment.
Evolutionary strategies with hyper-mutation algorithm (described in Chapter 4) was
used to estimate the parameters of the model. The objective function defined in the meth-
ods section was minimized to fit the model to experimentally measured time courses of
multiple species across 3 different experimental conditions (Fig. 14). The fitted model ex-
plains well the dynamics of i) pSTAT6 in Jurkat cells following IL-4 stimulation with or
without pretreatment by either MG132 or CHX (Fig. 14a, b); ii) total STAT6 following
IL-4 stimulation with or without MG132 (Fig. 14c); and iii) SOCS3 under the conditions
of IL-4 stimulation with or without inhibition by CHX(Fig. 14d).
3.3.5 Model successfully predicts behavior under extremes of intracellular redox
state
To validate the model we tested its ability to predict the dynamics of IL-4 signaling under


























Figure 13: The IL-4 signaling network. Regulatory mechanisms including ROS mediated
reversible phosphatase oxidation, proteasome mediated degradation of STAT6 and down-
regulation by SOCS are incorporated into the model. P1 and P2 represent PTPs acting
on STAT6 and the receptor complex, respectively; red edges, dephosphorylation reactions
catalyzed by indicated phosphatases; arrows pointing into other edges, enzyme catalyzed
reactions; Φ, infinite sources or sinks; purple edges and nodes, points affected by CHX
in the model; blue edges and nodes, points affected by MG132. Intermediate complexes
































































Figure 14: Model of IL-4 pathway fitted to experimental data. Parameters of the model
were estimated to fit multiple species across 3 different experimental conditions. (a) To-
tal phosphorylated STAT6 (cytosolic and nuclear) under IL-4 stimulation with or without
MG132 pretreatment. (b) Total pSTAT6 under IL-4 stimulation with or without CHX pre-
treatment. (c) Total STAT6 (phosphorylated and unphosphorylated, cytosolic and nuclear)
under IL-4 stimulation with or without MG132 pretreatment. (d) Generic SOCS molecule
of the model fitted to experimental measurements of SOCS3 under IL-4 stimulation with or





































Figure 15: Model predicts behavior under extremes of redox state. (a) DPI pretreatment
and addition of exogenous H2O2 with IL-4 stimulation were simulated using the fitted
model. The predictions of the model overlayed with quantitative experimental data. (b)
ROS profiles used to simulate DPI pretreatment and the effect of exogenous H2O2.
by IL-4 stimulation and addition of exogenous H2O2 along with IL-4 were simulated us-
ing the fitted model. The experimentally measured ROS profile under DPI pretreatment
(Fig. 15a) was used as input to simulate the effect of DPI in the model. To mimic the
effect of 10 µM exogenous H2O2 added along with IL-4, a large bolus of exponentially
decaying ROS was added to the experimentally measured ROS profile under IL-4 treat-
ment (Fig. 15a). The model predicted severely attenuated STAT6 phosphorylation under
DPI pretreatment, whereas addition of exogenous H2O2 with IL-4 was predicted to amplify
STAT6 phosphorylation in comparison to IL-4 treatment alone (Fig. 15b). Both these pre-
dictions matched quantitatively with experimental results, showing that the model is robust
enough to predict the dynamics of IL-4 signaling over a wide range of redox conditions.
We attempted to further validate the model using the J45.01 cell line, a derivative of
the Jurkat cell line. However, due to difficulty in characterizing the differential expression
of multiple proteins in the J45.01 cells, we decided not to use these cells to test the model
(details in Section B.5).
3.4 Discussion
With the recognition of reactive oxygen species as important regulators of cell signaling,
new targets of thiol-based oxidative regulation are being discovered with consistent reg-
ularity. Even though most of these redox sensors seem to rely on the same principle of
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cysteine thiol post-translational modification, their responses to oxidation can be very dif-
ferent [61]. For example, cysteine oxidation can result in loss of phosphatase activity in
PTPs, loss of kinase activity in JAKs or altered subcellular localization of TCPTP. Since
all of these processes are driven by the same underlying chemistry, it follows that given
equal access to ROS, all these processes could take place simultaneously. Since the effects
of multiple redox regulated changes in a given context may not always be consistent, in-
ferring the underlying mechanism based on experimental data becomes challenging. For
instance, in the context of IL-4 signaling, a heightened oxidative state can lead to PTP inac-
tivation resulting in signal amplification, but can also cause JAK inactivation which would
have the effect of attenuating the signal. While the individual outcomes of PTP or JAK
oxidation are relatively easier to predict in a qualitative manner, the joint outcome of these
changes is much harder to guess. Of course, ROS mediated regulation does not operate in a
vacuum and overlaying it with other modes of regulation that are independent of ROS fur-
ther complicates the picture. Recognizing this complexity, we have adopted a quantitative,
systems level approach in our work to infer the mechanisms of redox regulation in the IL-4
pathway and found strong evidence to support reversible oxidative inactivation of PTPs as
the dominant mode of ROS mediated regulation.
Jurkat cells were observed to quickly increase intracellular oxidation in response to
IL-4, and DPI was able to suppress this ROS production. DPI is a flavoprotein inhibitor
and known to inhibit the activity of NOX family enzymes. It has previously been shown
that IL-4 signaling activates NOX1 and NOX5L in A549 cells to induce ROS production
and DPI inhibits this [130]. Jurkat cells have been reported to express NOX1 [13] which
could be involved in IL-4 induced transient ROS production in these cells. Suppression
of ROS by DPI pretreatment significantly lowered baseline STAT6 phosphorylation and
severely attenuated pSTAT6 response to IL-4 treatment, indicating that the ROS produced
by activation of IL-4 receptor were playing an important role in the signaling pathway. The
oxidation of CM-H2DCFDA at the 0 min time point was also lower in the DPI pretreated
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cells (Fig. 7a). We interpret this as maintenance of a positive concentration of ROS in
the basal state keeping a fraction of STAT6 in the phosphorylated state. Failure of the DPI
treated cells to respond to IL-4 suggests that baseline ROS also have a role in sustaining the
system in a "primed" state so that it is ready to quickly respond to an activating stimulus.
Supplementing IL-4 induced ROS with exogenous H2O2 amplified the pSTAT6 response;
however, on its own, the same concentration of H2O2 did not elicit STAT6 phosphorylation.
These observations taken together suggest that ROS may be playing two roles; first, to keep
the system ready to respond to an input signal and second, to amplify the response once it
is initiated by IL-4 input.
Having confirmed that IL-4 signaling in Jurkat cells is redox regulated, we used com-
putational analysis relying on quantitative as well as qualitative information obtained ex-
perimentally to understand the control mechanisms by which ROS regulate IL-4 signaling.
Experimentally acquired time course of IL-4 induced STAT6 phosphorylation in Jurkat
cells had a distinctive shape presenting slowly oscillating dynamics over a two hour time
period. This feature combined with simplified models of the pathway proved a remarkably
useful tool for selecting models based simply on their ability to reproduce experiment-like
pSTAT6 oscillations. When possible combinations of likely mechanisms were systemat-
ically examined, PTP oxidation stood out as the most likely mechanism by which ROS
mediated regulation can take place. The other mechanisms considered, namely, JAK ox-
idation and ROS mediated PTP translocation, were not sufficient on their own to explain
the observed dynamics. They did reproduce the oscillatory behavior when assumed to
operate in tandem with PTP oxidation, but with a lower success rate and poorer quantita-
tive matching with experimental data. Therefore, even though model complexity increased
when additional redox regulatory mechanisms were added along with PTP oxidation, the
quality of prediction of the model only worsened when tested within the selected param-
eter bounds. This double failure of the more complex models is compelling evidence in
support of the PTP oxidation model which is not only parsimonious, but also matches the
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data better, both qualitatively and quantitatively.
Examination of the PTP oxidation model suggests a motif similar to a coherent feed
forward loop [84]. Addition of IL-4 results in rapid STAT6 phosphorylation resulting in
the first pSTAT6 peak, and the activated receptor simultaneously upregulates intracellular
ROS levels. As the effect of IL-4 starts to wane, the ROS oxidize enough PTPs to give a
second boost to pSTAT6 levels and contribute to sustaining the second peak. This requires
well tuned timings of the various events, which is why only a small number of the MC
simulations produce the oscillatory behavior. Inactivation of JAK by oxidation and ROS
mediated accumulation of PTP in the cytosol have a negative effect on STAT6 phosphory-
lation which is counter to the effect of PTP oxidation. These mechanisms, rather than help
sustain the second peak, act to abolish it and are probably not relevant in the IL-4 pathway.
The tendency of pSTAT to decrease non-monotonically after reaching its first maxi-
mum has been previously found in erythropoietin mediated JAK2/STAT5 signaling [139].
However, in that case only cytosolic STAT was experimentally observed. The behavior
was explained by phosphorylation dependent translocation of STAT5 into the nucleus and
delayed translocation of dephosphorylated STAT5 out of the nucleus. Another computa-
tional study reported slow, damped oscillations of nuclear pSTAT1 caused by a combination
of phosphorylation dependent nuclear-cytosolic movement of STAT1 and SOCS mediated
negative feedback [161]. In contrast to these studies, we have measured total pSTAT6
present in the nuclear and cytosolic compartments. While these existing models do not
attempt to explain the dynamics of total pSTAT and do not account for the role of ROS
in JAK/STAT signaling, they provide important clues regarding the possible mechanisms
that drive the observed oscillations. In agreement with these studies, we found in our anal-
ysis that phosphorylation dependent translocation of STAT6 was a very important control
mechanism. Independent studies have concluded that cycling of STAT6 between cytosol
and nucleus may or may not be be affected phosphorylation state depending on the cellular
system [4, 16]. Nonetheless, even when STAT6 trafficking was found to be independent of
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its phosphorylation state, greater residence time in the nucleus was reported for pSTAT6
due to DNA binding [16]. In agreement with these studies, our simulation results over-
whelmingly favored configurations that supported preferential nuclear localization of the
phosphorylated form. Future studies will be required to establish how nuclear shuttling of
STAT6 relates to its phosphorylation state in Jurkat cells.
While the kinase-phosphatase balance is an important determinant of signaling dynam-
ics, many other downregulation mechanisms are built into signaling networks to maintain
a tight control over the response. Proteasomal degradation of STAT is known to play a role
in downregulating cytokine signaling. Previous studies have found that inhibition of pro-
teasome stabilizes the phosphorylated form of some members of the STAT family but not
others [150]. In the case of STAT6, reported roles of proteasomal degradation have been
suggested to range from not being significant to being very important by affecting STAT6
phosphorylation either directly, or through intermediaries [4, 138, 49]. In Jurkat cells we
found that MG132 treatment increased IL-4 induced STAT6 phosphorylation and also sta-
bilized total STAT6 levels irrespective of IL-4 treatment. IL-4 treatment had the effect of
slightly increasing total STAT6 levels, whether or not the cells were treated with MG132.
This suggests that phosphorylation had the effect of protecting STAT6 from degradation.
Implementing a fixed rate of decay of unphosphorylated STAT6 and protecting pSTAT6
from degradation in the model helped explain the observed behavior under MG132 treat-
ment.
Feedback regulation through SOCS family proteins is another mechanism for regulating
JAK/STAT signaling. SOCS1 and SOCS3 expression has been variably reported to play a
role in IL-4 signaling, in some cases being found to be important suppressors while not
being significant in others [79, 49]. We measured SOCS3 protein in response to IL-4
and found that IL-4 treatment did not cause an increase in SOCS3 expression in 2 hours.
Cycloheximide treatment lowered the basal expression of SOCS3 which again could not be
increased by IL-4. In cycloheximide pretreated cells a much stronger response to IL-4 was
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seen at very early time points. This can be attributed to the decrease in baseline level of
SOCS3, and possibly other SOCS proteins such as SOCS1 which could be affecting IL-4
signaling in Jurkat cells. Not ruling out the involvement of other members of the SOCS
family, we included a generic SOCS molecule in our model which could be upregulated
by activated STAT6. Lowering the baseline level of this SOCS protein following CHX
pretreatment was central in explaining the observed dynamics of SOCS3 and pSTAT6 in
the model.
Based on inferences from analysis of reduced models of redox regulation and knowl-
edge gained from the experimental data, we have developed the most comprehensive model
to date of the IL-4 signaling pathway. The model incorporates redox regulation through re-
versible oxidation of PTPs and mechanisms for downregulation of the IL-4 signal through
proteasomal degradation of STAT6 as well as feedback regulation through SOCS proteins.
Interactions between these regulatory mechanisms allowed the model to successfully repro-
duce the dynamics of several molecular species over a variety of experimental conditions.
We tested the model in highly oxidizing and reducing conditions and found that predictions
of the model matched well with experimental data. The ability of the model to capture the
dynamics of IL-4 signaling under normal as well as extreme redox conditions provides
strong validation to our model. It also suggests that as a mechanism of redox regulation,
PTP oxidation could be a relevant phenomenon over a wide range of cellular redox states.
Collectively, the computational analysis indicates that while ROS mediated regulation is a
very important arm of the control machinery in IL-4 signaling, systemic behavior of the
pathway emerges from interactions of redox and non-redox regulatory mechanisms. For
instance, none of the redox regulation mechanisms considered in our analysis were suf-
ficient to explain pSTAT6 dynamics when working alone (Fig. 10), but combining them
with other ROS-independent mechanisms changed the behavior of the system qualitatively.
In other words, without considering the role of ROS-independent mechanisms we would
have reached a faulty conclusion. This results is a strong argument in favor of adopting a
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quantitative, systems based approach in trying to understand redox regulation of complex
signaling networks.
An important concern regarding the ability of ROS to play a significant role in mod-
ulating cell signaling has to do with the relatively slow rates of H2O2 mediated cysteine
oxidation in proteins. Since intracellular ROS concentration was modeled using direct scal-
ing of fluorescence based measurements, it could not be assigned real units in the model.
This means that protein oxidation rates are also to be understood in terms of these arbi-
trary units. However, the scaling factor was chosen such that the absolute value of ROS
concentration was in the order of 102 units of ROS in simulations of IL-4 stimulated cell.
Since intracellular ROS concentration is thought to be in the sub-micromolar range [135],
a 1:1 scaling can be assumed between the model’s arbitrary ROS units and nanomolarity.
In other words, assuming 1 unit of ROS in the model corresponds to 1 nM ROS in the real
cell would scale the simulated ROS level to the order of 100 nM, which is a reasonable
estimate of intracellular H2O2 concentration. Assuming this scaling, the estimated rate of
PTP oxidation turns out to be 2 × 106 M−1s−1. In a previously published systems model
of H2O2 dispersion in Jurkat cells the second order rate of H2O2 mediated oxidation was
estimated to range between 10 × 107 M−1s−1for the fastest reactions involving catalase and
peroxiredoxin to 10 × 104 M−1s−1for the average intracellular protein [1]. The estimated
rate of PTP oxidation in our model lies within this range. That it lies on the higher side is
consistent with the fact that PTPs have a higher propensity towards oxidation than the aver-
age protein. These rates are still much higher than in vitro measurements of PTP oxidation
rates, but in vitro estimates themselves have been found to be much slower than observed
rates of PTP oxidation in insulin signaling [141]. Several hypotheses have been proposed
to explain this high apparent rate of oxidation, including localization of ROS to create high
concentration and transfer of oxidation state through relay proteins, and this continues to
be an area of active investigation.
While computational models of ROS production and consumption have previously been
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developed for cells [1, 5], the question of how competing ROS dependent mechanisms reg-
ulate cell signaling has not been addressed in computational studies. This is the first study
to our knowledge that comprehensively explores the question of redox regulatory mech-
anisms in cell signaling using computational modeling. Aside from suggesting the most
likely mode of redox regulation in the IL-4 pathway, our results also demonstrate the value
of the integrative view in understanding redox regulation of cell signaling. Finally, the
model suggests several interesting avenues for experimental and computational investiga-
tion in the future. For example, is nuclear-cytosolic cycling of STAT6 unidirectional or is it
independent of phosphorylation state and the model is only reflecting increased residence
time of pSTAT6 in the nucleus due to mechanisms like DNA binding? Considering that lo-
cally elevated concentrations of ROS may be important for their regulatory effects, and that
cell membrane bound NOX1 may be an important source of ROS in IL-4 signaling, regions
close to the cell membrane are likely to have the highest localized ROS concentrations in
the cytosol. How is it then that JAK, which is constitutively bound to the receptor and al-
ways close to the membrane, contributes so little to regulating IL-4 signaling? The model
was simplified by pooling multiple phosphatases into two groups and assuming that each
pool has distinct targets in the form of STAT6 or the receptor/JAK complex. Furthermore,
both these pools were assumed to have identical access to ROS and identical oxidation/re-
duction rates. However, in reality phosphatases may be shared between different targets,
may have different rates of reduction and oxidation or may be more or less readily ac-
cessible by ROS. How can these factors be accounted for in the model and how do they
influence signaling dynamics? The model presents these and other questions that require




EVOLUTIONARY STRATEGY WITH HYPER-MUTATION: A
RESTART STRATEGY TO IMPROVE OPTIMUM FINDING
4.1 Introduction
An essential step in the construction of biologically relevant models is estimation of pa-
rameters to fit model behavior to measured biological data. A variety of optimization
algorithms are at a modeler’s disposal to determine parameter sets of ODE systems that
minimize the distance between model prediction and measured data [87], but because the
objective function in ODE systems cannot be explicitly determined, often derivative-free
approaches (the so called black-box methods), e.g., direct search methods [55, 96], sim-
ulated annealing [69], evolutionary computation methods [163] etc., are preferred. Such
methods are computationally expensive as they require solving of the ODE system at all
test points. Furthermore, ODE models with even a moderate amount of complexity often
have highly multimodal objective functions, making it hard to find the true global optimum
among the many local optima [6]. As a consequence of these factors, algorithms that can
get close to the global optimum in multi-dimensional search spaces with relative efficiency
are preferred.
Evolutionanary strategy (ES) is a population-based, stochastic, black box optimiza-
tion algorithm inspired by the process of biological evolution [125]. A comparative study
of several commonly used global optimization algorithms found that algorithms based on
ES performed better than competing algorithms when tested on a specific systems biol-
ogy model [91]. Starting with a random initial population of candidate solutions to the
optimization problem, ES operates by repeated application of the operators of mutation,
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recombination and selection to produce successive generations until defined stopping cri-
teria are satisfied [125]. The mutation operator is important for introducing variation in
the population and the strengths of mutations of all individuals are controlled by a set of
internal parameters known as strategy parameters or step sizes. The step sizes need to be
controlled, as very strong mutations can delay convergence and prevent directed evolu-
tion, while weak mutations can slow convergence and trap the solution in a local minimum
[102]. Different types of strategy parameter control methods have been developed for use
with ES, e.g., self-adaptation using mutative strategy parameter control and derandomiza-
tion of self-adapdation using CMA [48]. Irrespective of their implementation details, all
variants of ES utilize gradual damping of the step size to ensure convergence. As a result,
in later stages of the evolution as the population begins to converge the step size becomes
increasingly small, until the evolution slows down and the population tends to get trapped
in a local minimum. Because of the stochastic nature of ES, each optimization run is likely
to yield a different solution. This stochasticity is exploited to improve optimum finding
by using restart strategies, i.e, repeated execution of the optimization algorithm, possibly
with different settings each time, and selecting the best among several possible solutions
[58]. The main drawback of restart strategies is the extra computational cost incurred by
repeated runs of the optimization algorithm.
In this chapter a variant of ES is presented that uses a partial restart strategy [58] to im-
prove the global optimum finding ability of the algorithm without dramatically increasing
the computational cost. We have developed and empirically tested a simple method that
dynamically monitors the evolution of the fitness score and when required, operates on the
strategy parameters to create a subpopulation of hyper-mutants, hence the name ES-HM,
to help the evolving population escape local minima at later stages of the algorithm and
enable convergence to a better optimum. We tested the algorithm on a set of benchmarking
functions under a variety of conditions and found that ES-HM performed better than other
methods for several test functions under most conditions. An example of application to a
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systems biology problem is also presented; ES-HM was used to estimate the parameters
of a model of IL-4 signaling to fit the model to an experimentally derived data set. ES-
HM was able to find better solutions even when the parameters of the model were poorly
constrained.
4.2 Methods
The ES-HM algorithm described in Section 4.3.1 was implemented in Matlab. Source
code of the Matlab implementation is provided in Listing 1. A suite of test functions was
selected from a collection of benchmarking functions [140, 47] to assess the performance
of the algorithm. The 1) sphere, 2) Schwefel’s problem 2.21, 3) Rastrigin, 4) Ackley, 5)
Rosenbrock, 6) Griewank, 7) Gallagher’s Gaussian 21 peak, 8) rotated Weierstrass and 9)
rotated Lunacek bi-Rastrigin functions were selected to represent a combination of sep-
arable, non-separable, unimodal and multimodal functions. The functions are defined in
Appendix C.1.
The ODE model of the IL-4 pathway was coded and solved in Matlab. The ES-HM
implementation was used to estimate the parameters and the objective function was defined
as the root mean squared error between the model and average of normalized experimental
data, summed over all time points and experimental conditions.
4.3 Results
To overcome the problem of stagnating search in ES due to very small step size in later
stages of the search, we have developed a modification of the ES algorithm that scales
up the step sizes of the evolving individuals along randomly selected dimensions if, i) the
stopping criteria are satisfied; or ii) the evolution of the best score starts to stagnate over
time. To prevent superfluous restarts, the evolution is stopped if three successive restarts
result in no improvement of score or if a pre-set maximum number of restarts is achieved.
56
4.3.1 Evolutionary strategy with hyper-mutation
We present here the ES-HM algorithm in the context of a generic ES algorithm, but this
strategy could easily be applied to other variants of the algorithm. To minimize the ob-
jective function f : Rn → R the algorithm consists of the following steps, with Steps 5-8
representing the hyper-mutation modifications we have introduced.
1. Initialize a population of µ individuals, the parents, where each individual is com-
prised of a pair of real-valued n-vectors (xi,σi), ∀i ∈ {1, . . . , µ}, where xi and σi are
object parameters and step-sizes, respectively. Generation number, g = 1; number of
restarts, R = 0.
2. Recombine parents to generate λ new individuals, (x′i ,σ
′
i), i ∈ {1, . . . , λ}.
3. Mutation: For all i ∈ {1, . . . , λ}
(a) mutate strategy parameters, σ′i = σ
′ξi;





where, ξi and zi are real vectors whose values are determined by the specific
flavor of ES algorithm.
4. Selection: Evaluate the fitness of (x′i ,σ
′
i), ∀i ∈ {1, . . . , λ}. Select the fittest µ individ-
uals to become the parents for the next generation. sg = score of the fittest individual.
5. Check for stopping criteria and score stagnation. If
(a) a stopping criterion is satisfied; or
(b) if at least Ns generations have passed since last restart and the relative differ-
ences between scores of the fittest individuals over the last Ns generations are
less than a threshold θ (i.e, for g > Ns, if
|si − si+1|
si
< θ,∀i ∈ {g − Ns, . . . , g − 1})
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then go to step 6 to initiate hyper-mutation, otherwise, increment g by 1 and
return to step 2.
6. Increment restart count R by 1. bR = best score in generation g just before initiating
hyper-mutation.
7. Introduce hyper-mutants by randomly scaling up on an average a fraction φ of all the
step-sizes:
For the jth element σi j of the vector, σi, ∀i ∈ {1, . . . , µ}, and j ∈ {1, . . . , n} generate a
uniform random number r. If r < φ, σi j = σi j × ρ, ρ > 1. ρ determines the strength
of hyper-mutation.
8. If R > Rmax, stop.
9. If bR, the best score just before a new round of hyper-mutation is initiated, does not
improve for 3 successive value of R, stop.
ES-HM introduces 4 new internal parameters into the algorithm, namely, Ns and θ,
which determine the stagnation criteria and φ and ρ, which define hyper-mutant frequency
and hyper-mutation strength. For all subsequent analyses we have chosen, Ns = n, the prob-
lem dimension, and θ = 1%. We have implemented the (µ, λ) ES-HM algorithm in Matlab
(Listing 1) with mutative strategy parameter control and multi-parent-recombination as de-
scribed in Appendix C.2 [125]. Fig. 16 shows a comparison of the search characteristics of
(µ, λ)-ES compared with (µ, λ)-ES-HM for the Ackley function. Search trajectories of ES
and ES-HM are superimposed on the contour plot of the 2-dimensional Ackley function.
The search was initialized identically for both algorithms to enable comparison. While
ES quickly stopped in a local minimum (Fig. 16a), ES-HM was able to escape this mini-
mum and reached close to the global optimum (Fig. 16b). A similar comparison of the two
methods for the 30-dimensional Ackley function was performed (Fig. 16c). Starting under
identical settings, the two methods proceeded identically for some time until ES stopped.
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Figure 16: Comparison of search characteristics of ES-HM with ES. (µ, λ)-ES and
ES-HM were used to find the global optimum of the 2-dimensional Ackley function in
[−30, 30]2 (contour plots in a and b). The search was started far from the optimum (0, 0)
by forcing the initial population in [14.5, 15]2. The random number generator was seeded
identically for ES and ES-HM to enable comparison. Black lines, trajectory of best score;
black dots, coordinates of the best individual; green dot, starting position. (a) ES stopped
quickly in a local minimum. (b) ES-HM took a longer time but ended close to the global
optimum. (c) Similar comparison on 30-dimensional Ackley function by starting (µ, λ)-ES
and ES-HM with identically seeded random number generator. Best score for each gen-
eration is plotted. Search is identical in the beginning and scores coincide. ES stops in
less than 200 iterations; ES-HM introduces hyper-mutants several times (spikes) ultimately
improving the score by nearly 2 orders of magnitude.
ES-HM continued the search with increased step sizes and although the new step sizes of-
ten resulted in temporary worsening of the score (spikes in red line Fig. 16c), ultimately
a better score was found. In the example shown in Fig. 16c, the score was improved by
nearly two orders of magnitude by ES-HM.
4.4 ES-HM shows improved performance compared to other ES-based
restart algorithms
As is clear from the description of the algorithm and Fig. 16c, ES-HM is a type of restart
strategy. However, instead of forcing a complete restart, it only changes some randomly
selected strategy parameters and can therefore be thought of as a soft or partial restart
method [58]. To further assess the performance of the ES-HM algorithm, we implemented
a (µ, λ) version of ES-HM as described above and compared it with 3 variants of ES, two
of which are restart methods. First, (µ, λ)-ES-HM was compared with (µ, λ)-ES with muta-
tive strategy parameter control and multi-parent recombination (hereafter, pure ES). Next,
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Figure 17: Two-dimensional representation of test function used.
we compared ES-HM with a naive restart algorithm, where the pure ES algorithm was
independently run 10 times and the best solution was accepted (hereafter, naive restart). Fi-
nally, we compared it with an algorithm similar to the ES-IPOP restart strategy [8], where
the population size is doubled with each restart and evolution stops when an upper limit on
number of restarts or objective function evaluations is reached.
Since the optimization algorithm needs to strike a balance between the goodness of fit
and the computational cost, we devised a performance score that takes into account both
the quality of score and the cost of computation to generate a comparative score S A2/A1 of
algorithm A2 against algorithm A1 as follows:








where, s̃A represents the median score obtained from independent runs of algorithm
A and ẽA is the median number of objective function evaluations required by the algo-
rithm. This metric implies that an x-fold improvement (or worsening) of the optimized
score is exactly offset by an x-fold worsening (or improvement) of the computational cost.
In other words, a score of 0 implies identical performance, whereas a positive (negative)
score means the performance of A2 is better (worse) than A1. A more generalized perfor-
mance score that assigns different weights to fitness of the solution and computational cost
could be obtained by using different log bases for the two ratios, but we have used a log
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Table 1: Frequency with which each (φ, ρ) pair produced the best performance score for
ES-HM against pure ES according to Eq. (1). A total of 54 conditions were run by varying
test functions (all 9 types), problem dimension (10, 30 and 50) and population size (bn/3c
and n) as described in Fig. 18.
ρ φ = 0.2 φ = 0.6 φ = 0.8
2 17 3 4
20 13 5 3
100 3 0 6
base of 2 for both terms in our analysis.
Performance of the algorithms was compared using 9 different test functions (2 dimen-
sional versions in Fig. 17, equations in Appendix C.1). The parameters φ and ρwere varied
to study their influence on performance. For each test function, 30 independent runs were
executed for each (φ, ρ) pair to calculate the performance scores as defined in Eq. (1). Prob-
lem dimensions (i.e., n) of 10, 30 and 50 were chosen and the number of parents, µ, was
chosen to be bn/3c or n. As recommended in [125], λ was fixed at 6µ. Fig. 18a shows the
performance of ES-HM against pure ES for all the test functions over different problem
dimensions and population sizes. For a given test function and (µ, λ) value (i.e., a given
cell in the heat maps in Fig. 18), 9 pairs of (φ, ρ) values were used in independent runs. The
(φ, ρ) pair for which the performance score of ES-HM was best was used for each cell in
the heat maps in Fig. 18. ES-HM performed better than ES for most test functions under
various conditions producing positive performance scores. However, the performance was
worse than ES under most conditions for the Rastrigin and Lunacek functions. ES-HM
was next compared against naive restart ES and the scores were found to favor ES-HM for
almost all test conditions (Fig. 18b). ES-HM also compared favorably against ES-IPOP
(Fig. 18c).
The frequency with which each hyper-mutation frequency and strength pair, (φ, ρ), pro-
duced the best performance score for ES-HM against ES when run over the 54 different
conditions in Fig. 18a (9 test functions times 6 (µ, λ) pairs), is shown in Table 1. The best
performance scores were most frequently obtained for the lowest values of φ and ρ.
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Table 2: Comparison of the fittest solutions found by ES-HM to those found by ES from
30 independent runs. The internal parameters of the algorithms were varied as described
in Fig. 18. For each cell in the table, the (φ, ρ) pair which produced the fittest solution
was chosen for ES-HM. FR (fitness ratio) is the ratio of fittest solution found by ES to that
found by ES-HM. CR (cost ratio) is the ratio of number of function evaluation required by
ES to find the fittest solution to that required by ES-HM. * indicates fitness scores found
by ES-HM were significantly lower than those found by ES at a significance of 0.05 in
one-sided 2-sample Kolmogorov-Smirnov test
n = 10 n = 30 n = 50
µ = n/3 µ = n µ = n/3 µ = n µ = n/3 µ = n
Fun FR CR FR CR FR CR FR CR FR CR FR CR
Sp 5.9* 0.7 3.6* 0.8 2.4* 0.9 2.4* 0.8 2.2* 0.9 1.8* 0.8
Sc 7.0* 0.3 2.0* 0.8 31.8* 0.4* 2.1* 0.8 9.5* 0.4 3.4* 0.7
Ra 3.4* 0.3 3.0 0.4 1.3 0.5 1.2 0.4 1.2 0.8 1.5 0.6
Ac 6.6 0.7 1.3* 0.8 2.8* 0.7 1.6* 0.8 1.7* 0.8 1.5* 0.8
Ro 72.7 1.0 0.1 2.3 21.5 1.0 0.1 1.9 5.6 0.8 0.7 1.8
Gr 3.7* 0.6 6.3* 0.9 2.1* 0.9 2.0* 0.8 1.7* 0.8 1.8* 0.8
Lu 10.7* 0.6 3.7* 0.9 3.7* 0.6 3.7* 0.8 2.7* 0.7 2.7* 0.7
We 2.6 5.7 2.1 29.2 2.0 15.1 1.0 5.0 1.6 9.5 1.0 4.1
GG 1.0 0.4 4.0 0.3 1.3* .7 1.8* 0.8 1.0* 0.3 2.1 0.2
As pure-ES performed closest to ES-HM (compare Fig. 18a against b and c), we com-
pared the fittest solutions found using ES and ES-HM and their relative computational costs
(Table 2). ES-HM usually found better fitness values than ES for lower problem dimen-
sions and for the smaller population size for a given problem dimension. The table also
shows that ES-HM usually found a better score than ES but at a greater computational cost,
which is to be expected since ES-HM uses restarts. The Weierstrass function was a notable
exception to this trend where the computational cost was much lower for ES-HM.
4.5 ES-HM improves data fitting in an ODE model of IL-4 signaling
As ES-HM showed better optimum finding ability than the other algorithms for several
test functions, we next tested it on a problem that is more representative of parameter
optimization in systems biology modeling. We developed a simplified ODE model of redox
regulation in IL-4 signaling and used the algorithm to optimize its parameters to fit the
model to experimentally measured time-course data.
62
Figure 18: Performance of ES-HM compared with other ES-based algorithms. Perfor-
mance score Eq. (1), (a) S ES−HM/ES , of ES-HM against pure ES, (b) naive restart and (c)
ES-IPOP. Function names are abbreviated to first 2 letters. n denotes problem dimension;
µ, the number of parents was varied over {bn/3c, n} and λ was fixed at 6µ. φ and ρ were
varied over 0.2, 0.6, 0.8 and 2, 20, 100, respectively; for each of the 9 (φ, ρ) pairs ES-HM
was run 30 times; ES was run 30 times for each test function; naive restart was executed
3 times; IPOP was executed once. Fewer runs were performed for the restart methods be-
cause they inherently include multiple runs of ES algorithm. Of the 9 (φ, ρ) pairs for each
cell on the heat maps, the pair which produced the best performance score for ES-HM was
selected.
4.5.1 Experimental data and ODE model
Experimentally measured pSTAT6 time courses with and without DPI pretreatment (as
shown in Chapter 3) were used. A model of IL-4 signaling with phosphatase oxidation as a
mechanism of redox regulation was created (Fig. 19; this is a simplified model of the fully
detailed IL-4 model and was used only for testing the optimization algorithms). Equations
comprising the ODE system are described in Appendix C.3.
4.5.2 Parameter estimation and comparison of algorithms
We used ES-HM to optimize 18 parameters of the model, which include initial values and
rate constants of the ODE system (Appendix C.3), and compared its performance with
ES. When assigned very broad ranges (lower limit 10−6 and upper limit 106) to the values
of all parameters, both ES and ES-HM could not produce satisfactory fits after several
independent runs. Therefore, we adjusted the parameter values by hand to obtain a better
first guess that produced a reasonable fit as assessed by visual inspection (Appendix C.3).
The parameter optimization algorithms were then applied to search in parameter space
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Figure 19: Schematic of the IL-4 signaling pathway representing the components mod-
eled in the ODE system. Symbols used for the rate constants in the ODE model are shown
in italicized text. This simplified model was created only to test the optimization algorithms
and does not represent the actual model of IL-4 signaling developed in Chapter 3
bounded by values 1000 fold lower and 1000 fold higher than the first guess for each
parameter.
9 different (φ, ρ) pairs were used in the ES-HM algorithm and 10 independent runs were
executed for each pair resulting in 90 independent runs. Distributions of the parameters and
scores for all 9 conditions are shown in Appendix C.4. Results from all 90 runs combined
together are presented in Fig. 20b showing that the optimized values had a wide spread
over the search range for most parameters. To compare ES-HM with ES, we executed 90
independent runs of ES over the same search range; the resulting distribution of optimized
parameters is shown in Fig. 20a. Comparison of Fig. 20a against Fig. 20b shows that most
parameters have a smaller spread for ES as compared to ES-HM. The distributions of the
fitness scores obtained from the 90 independent runs of both methods are shown in Fig. 20c.
The median score found by ES-HM was only marginally better than that obtained by using
ES but the fittest solution found by ES-HM improved upon that found by ES by about
27%. Visual inspection of the fits generated by the best parameter vectors from both the
algorithms confirms that ES-HM produces the better fit (Fig. 21). The parameter vectors
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Figure 20: Box-whisker plots of parameter values and score distributions. Search space
was limited to 1000 fold on either side of the first guess for each parameter value for a, b
and c, and 5 fold for d, e and f. 90 independent optimizations were performed for ES. Dis-
tribution of optimized value for each parameter is shown as ratio of the initial guess (a, d).
For ES-HM φ and ρ were varied over 0.2, 0.6, 0.8 and 2, 100, 1000, respectively, resulting
in 9 (φ, ρ) pairs; for each pair 10 independent optimizations were executed. Results from
all 90 runs were combined to generate the distributions for ES-HM (b, e). Distribution of
scores corresponding to the distribution of parameter values for 1000 fold (c) and 5 fold (f)
search ranges. µ = n/3, λ = 6µ
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Figure 21: Fits generated by ES and ES-HM algorithms. Fitted pSTAT6 under IL-4
treatment (a) without and (b) with DPI pre-treatment. Fits corresponding to the best fitness
score generated by ES and ES-HM when the search range is 1000 fold around initial guess
(ES, wide and ES-HM, wide); fits corresponding to median fitness score generated when
the search range is 5 fold around initial guess (ES, narrow and ES-HM narrow).
corresponding to the median scores for both algorithms produced poor fits.
To further study the performance of ES-HM against ES, we constrained the size of
the search space assigning upper and lower bounds to 5 times higher or lower than the
first guess for each parameter and repeated our analysis. The parameter distributions are
shown in Fig. 20d and e. Comparison of the fitness distributions resulting from ES and ES-
HM shows that ES-HM found a lower median score and the best score found by ES-HM
was also lower than that determined using ES (Fig. 20f). Moreover, with the more tightly
constrained search range the distribution of scores found by ES-HM was narrower than that
for ES. With the narrowed down search range, the parameter vectors returned by both the
algorithms produced good fits. Fits corresponding to the median scores returned by both
the algorithms are shown in Fig. 21. It is clear from visual inspection that the parameter
vector corresponding to ES-HM produced the better fit, especially with respect to the DPI
treated condition.
4.6 Discussion
In this work we have presented a modification of the evolutionary strategy algorithm that
improves its performance by introducing hyper-mutants into the evolving population when
the evolution approaches stagnation. The hyper-mutants increase the step-size of the search
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which may enable a jump out of local minima or accelerate the rate at which the minimum
is approached. This method is essentially a partial restart strategy where instead of resetting
all the parameters with each restart, only the step sizes are perturbed. The introduction of
hyper-mutants to increase step sizes of the ES algorithm is conceptually very similar to the
idea or reheating in simulated annealing, where the temperature of the annealing system is
raised as the annealing converges [101, 3]. An advantage of the ES-HM algorithm is that
unlike a complete restart, successive rounds of hyper-mutation lead to quicker convergence,
therefore increasing the probability of improving the search without incurring as much
computational cost as a complete restart might. A second benefit of the ES-HM algorithm is
that it is independent of the other operators used in evolutionary strategy-based algorithms;
therefore, hyper-mutation can be easily combined with different types of ES algorithms.
The major limitation of the algorithm is that because the object parameters are not perturbed
during each restart, it is possible that despite the increased step-sizes, searches following
partial restarts will not be able to find better optima that are further away from the current
value of the object parameters.
We empirically tested the performance of a (µ, λ) implementation of ES-HM to opti-
mize real valued parameters of a suite of 9 test functions under a variety of conditions. To
compare the performance of algorithms we devised a new performance metric that takes
into account both the extent of improvement of the score as well as the cost of computation.
Unlike some performance metrics that ignore the actual value of the optimized score by dis-
cretizing each run as a success or failure [7], the performance measure we have proposed
can provide a better view of compromise that the algorithm has to make in terms of cost
and benefit. We found that ES-HM outperformed naive restart and ES-IPOP type restart
for a majority of the conditions tested. This can be largely attributed to the huge computa-
tional effort required by complete restart strategies. While the optimum finding abilities of
the complete restart methods may be similar to ES-HM, the much higher cost offsets their
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advantage. Because ES-HM is also a restart strategy, it typically runs over a greater num-
ber of generations than pure ES, implying that ES-HM is usually the more expensive of the
two methods. Despite this limitation, a comparison of ES and ES-HM using the perfor-
mance score in Eq. (1) showed that ES-HM performed better than ES for a large number of
test conditions and objective functions. Surprisingly, for the Weierstrass function ES-HM
not only improved the fitness score over ES for many test conditions, it managed to do so
in fewer iterations. This happens because the Weierstrass function has a large number of
very closely spaced minima; this leads to very quick stagnation of the search and ES-HM
forces a restart. Again, because of the construction of the function, restarted searches hit
stagnation quickly and after a quick succession of restarts, ES-HM reaches its threshold
on the total number of restarts and stops. ES on the other hand, typically gets stuck in a
local minimum and continues to refine its search in a confined parameter space without any
significant improvement to the fitness score. This shows that on some difficult objective
function surfaces ES-HM may also improve the cost of optimization despite being a restart
strategy.
Our empirical tests with the algorithm enabled us to find the internal parameters of ES-
HM that produced the best results for these test functions. We found that keeping hyper-
mutant frequency and hyper-mutation strength parameters low usually produced better out-
put in terms of the performance score of ES-HM compared to other algorithms. Introducing
large perturbations or perturbing too many strategy parameters can introduce randomness in
the search and even though it has the possibility of enabling the search to find far removed
optima, it can lead to undirected evolution resulting in poorer search results or much higher
computational costs.
To demonstrate a more practical application of the algorithm to a problem relevant for
modeling in systems biology, we used ES-HM to optimize the parameters of an ODE model
of IL-4 signaling. The structure of the model was based on knowledge from the literature
68
and the parameters were optimized to fit the behavior of the model to experimentally ac-
quired data on redox regulation of IL-4 signaling. For this problem we focused on the
goodness of fit alone, but we note that the typical ratio of computational cost of ES-HM
against ES was similar to that seen for the test functions (Table 2). During the fitting ex-
ercise we found that most parameters of our model could vary over very large ranges of
values without affecting the fitness score too much. When searched over a loosely con-
strained parameter space, ES-HM showed a broader distribution of fitted parameter values
as well as scores as compared to ES (Fig. 20a, b and c). Thus the hyper-mutation strategy
enabled exploration of a larger portion of the search space and the best scores found by
ES-HM surpassed the best scores found by ES. However, the broader distribution of scores
also meant that worst scores found by ES-HM were poorer than the worst scores found by
ES. Restricting the search space to a narrower range gave a double advantage to ES-HM
so that scores found by ES-HM were better than those found by ES at both ends of the
spectrum, even though the parameter values were still broadly distributed over the search
space.
Our results show that hyper-mutation strategy can improve the search characteristics
of ES for a wide variety of objective functions including complex parameter optimization
problems encountered in ODE models commonly used in systems biology. Advantages
could be seen in terms of improved optimum finding as well as cost reduction, depending
on the objective function. Furthermore, when the computational cost was increased, the
gain in fitness was usually sufficient to offset the increased cost. Finally, better results can
be expected in situations with both poorly and well constrained parameter spaces when






In 1999, Hartwell et al. introduced the concept of modular biology, where a functional
module is created by interacting molecules collectively performing a discrete function.
The functional modules could in turn be connected in different patterns resulting in higher
level properties of the system. Such a modular construction is advantageous in terms of
making the system both robust and evolvable at the same time – the individual modules
could be robust to perturbations but connections between them could be changed to allow
for changes in phenotype [51]. Intuitively, the requirements of evolvability and robustness
seem contradictory, since a robust system should be insensitive to external perturbation
whereas an evolvable system must be sensitive to environmental change. Reconciling the
divergent requirements of evolvability and robustness requires knowledge of the connec-
tions between the functional units constituting the system and an appreciation of how each
module integrates information arriving from multiple inputs.
Signaling pathways fit the modular description quite well by virtue of enzyme-substrate
specificity in biochemical reactions; that is to say that activation of a particular receptor ac-
tivates specific enzymes that act on well-defined targets. Therefore, even though there may
not be spatial segregation between components of distinct signaling pathways, enzyme-
substrate specificity ensures isolation of active reactions [51]. Introducing a non-specific
actor in the context of modular signaling pathways allows for a mechanism to integrate
the modules. As introduced in Chapter 1, ROS can play this role because of their relative
1Modified from [78]
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promiscuity when compared to enzyme catalyzed reactions. In other words, the effects
of ROS, instead of being directed towards specific proteins, are directed towards specific
amino acid residues (Section 1.3). This could allow ROS produced by activation of one sig-
naling pathway to influence another redox sensitive pathway. Recognizing this possibility,
quantitative analysis of the potential of ROS to act as integrators of signaling modules was
carried out and the functional consequences of ROS mediated crosstalk were examined.
Mathematical tools are required to quantitatively study how function can be segregated
in signaling modules while still allowing for integration through agents like ROS. The con-
cept of degeneracy has previously been developed to study these properties in complex
biological systems. As first introduced in [144], structural complexity can be understood
in terms of the interplay between specialization of functions in individual modules (func-
tional segregation) and the ability of the modules to interact and perform functions coher-
ently (functional integration). A highly complex system maintains segregation of func-
tion in modules while still allowing for functional integration through connections between
modules [145]. Degeneracy is defined as a measure of how well functionally independent
modules can interact to produce the same output. Modules that are structural duplicates
form a completely redundant system and always produce the same output; degenerate sys-
tems arise from structurally distinct modules with different outputs interacting to produce
the same output under certain conditions [31]. In the context of interacting signaling path-
ways, existence of degeneracy can be interpreted to mean that while the interacting sig-
naling pathways perform separate functions, the possibility exists that the pathways could
cooperate with, or compensate for each other to produce the same output. This intuitive un-
derstanding of the concept of degeneracy can be applied more meaningfully to biological
networks if degeneracy is defined mathematically.
A mathematical definition of degeneracy was first introduced in the context of neural
networks [144]. However, since regulatory features of cell signaling networks are often
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described using differential systems, theory compatible with kinetic description of bio-
chemical reactions rather than neural network [145] or logic-based descriptions [118] is
required. Although some features like regulation and robustness of biochemical networks
have been studied quantitatively [70, 118], degeneracy and complexity were not formalized
mathematically in terms of ordinary differential equation until very recently [78].
In this chapter an explanation of the definition developed by Li et al. is first provided.
This definition is then used to study ROS mediated crosstalk between the IL-4 and erythro-
poietin (Epo) pathways. Finally, implications of ROS mediated crosstalk are discussed.
5.2 Results
5.2.1 Definition of degeneracy for a differential system
The strategy used in [78] to determine the degeneracy of a differential system is described
here. A stochastic perturbation is first injected into the differential system making the
modules of the network stochastic processes. Two modules with strong functional connec-
tivity are expected to have high statistical correlation; conversely, functionally independent
components must be statistically independent. The statistical connectivity between two
components I1 and I2 is measured using the mutual information, MI(I1; I2), of the compo-
nents. Network degeneracy is then quantified using a linear combination of the calculated
MI between components as shown by the following illustrative example.
Consider a simple network consisting of three modules A, B and C as shown in Fig. 22.
A and B serve as inputs while C is the output. If module A has a functional relationship
with the output module C, the mutual information between the two is high. Similarly,
if modules B and C share high mutual information, they are functionally related as well.
However, both modules A and B being functionally related to the output is not enough for
degeneracy. We also require A and B to be structurally different. This can be checked by




Figure 22: A simplified example of a modular biological network
comparing it with the mutual information A and B share individually with C. The value
D = MI(A; C) + MI(B; C) − MI({A, B}; C) (2)
thus measures the degeneracy, or how much more correlation the inputs A and B share with
the output C than expected. This definition enables exploration of degeneracy in signaling
networks in a quantitative manner.
5.2.2 ROS mediated crosstalk increases the degeneracy of IL-4 and Epo signaling
pathways
ROS mediated crosstalk between the IL-4 and Epo pathways was examined in terms of
the effects of crosstalk on degeneracy. Epo is a cytokine that plays an important role in
erythrocyte development and signals through the JAK2/STAT5 pathway [116]. A previous
study has shown that both IL-4 and Epo signaling can increase intracellular ROS produc-
tion, and ROS generated by Epo signaling could affect the IL-4 pathway by amplifying
IL-4 mediated JAK3/STAT6 signaling [130].
As illustrated in Chapter 2 and Chapter 3, phosphatase oxidation is a crucial mechanism
for redox regulation of signaling pathways. Based on this knowledge, we hypothesized
that a redox sensitive phosphatase could be the common link between the two pathways
that is affected by ROS, thus enabling crosstalk between the pathways. Previous studies
have shown that PTP1B is an important phosphatase in both IL-4 and Epo signaling path-
ways. In the IL-4 pathway it directly dephosphorylates STAT6 whereas the substrate of
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PTP1B in the Epo pathway is JAK2 [81, 93]. PTP1B is also susceptible to physiologi-
cal ROS-mediated oxidative inactivation [130]. This information was compiled to create a
simplified, hypothetical model of IL-4/Epo crosstalk as shown in Fig. 23a. The details of
model implementation are provided in Appendix D.
The model in Fig. 23a was used to empirically study the degeneracy of the pathway
under different scenarios. The receptors IL-4R and EpoR were chosen as a pair of inputs
to the system and activated STAT molecules (STAT5* and STAT6* in Fig. 23a) as the
output. Using the “Lyapunov algorithm” described in [78], the model in Fig. 23a was
found to be degenerate with the calculated value of degeneracy equal to 0.4267. To check
if ROS mediated crosstalk contributed to this value of degeneracy, we abrogated all cross-
talk by switching off ROS production and regulation by the common phosphatase PTP1B to
get independent signaling systems shown in Fig. 23b. The calculated value of degeneracy
decreased by more than 99% for this system as compared to the pathway in Fig. 23a and
the value was calculated to be 0.0016. This demonstrates that ROS mediated cross-talk
between the signaling pathways is an important contributor to the degeneracy of the system.
Complexity in biological networks is thought to be related to degeneracy and systems
with greater complexity are likely to be more degenerate [31]. Fully redundant systems,
that is systems with exactly identical modules, can also have high structural complexity
by means of crosstalking connections between modules. However, a redundant system is
by definition not degenerate because the redundant modules can only perform identical
functions, irrespective of the conditions. To test how a redundant system compares with
a degenerate system, we modified the pathway in Fig. 23a to that shown in Fig. 23c by
inserting some hypothetical connections. This was done to ensure that the two modules
were structurally identical and affected the output (STAT5* and STAT6*) identically. The
rate parameters were also identical for the two modules resulting in a completely redun-
dant system where EpoR and IL-4R affect STAT5 and STAT6 identically. The redundant
































Figure 23: Hypothetical model of crosstalk between IL-4 and Epo pathways. a) The core
JAK-STAT modules of IL-4R and EpoR pathways with crosstalk. Both modules are reg-
ulated by PTP1B, both generate ROS which oxidatively inactivates PTP1B. b) The links
connecting the two modules were abolished resulting in independent IL-4R and EpoR sig-
naling modules. The absence of crosstalk resulted in reduced degeneracy. c) The edges
in panel A were modified to construct a hypothetical signaling system with completely
redundant modules with crosstalk. Redundant networks were found to have reduced de-
generacy. * indicates phosphorylated protein; ox, oxidized; red, reduced; arrows pointing
at other edges, catalyzed reactions; dashed arrows entering into species, constant produc-
tion; dashed arrows exiting species, first order decay; species highlighted in black, inputs;
species highlighted in blue, outputs ; D, degeneracy.
75
than 68% as compared to the value calculated for the system in Fig. 23a. Therefore, the
calculated value of degeneracy agreed with the notion that redundancy does not lead to
degeneracy even if the system is richly connected and complex.
5.3 Discussion
Theoretical considerations, i.e, the potential of ROS to non-specifically affect protein func-
tion, as well as experimental results [94, 130] suggest that ROS could be important medi-
ators of crosstalk between signaling pathways. Given the relatively non-specific nature of
ROS mediated regulation, is there any advantage in biological terms in using ROS as me-
diators of crosstalk between signaling pathways? The notion of degeneracy in biological
networks was applied in an attempt to answer this question. Degeneracy can be generally
understood as the ability of structurally distinct components of a system to behave similarly
under certain conditions, while the behavior may be different under other conditions. This
definition of degeneracy appears to focus on how structural modules are organized and how
they interact, but has greater significance because of profound connections of degeneracy
with complexity, robustness and evolvability [156]. Mathematical formalisms developed to
study degeneracy in neural networks as well as in differential systems indicate that degen-
eracy and complexity have strong positive correlation [145, 78]. Similarly, robustness and
high degeneracy have been suggested to increase together [78]. Finally, highly degenerate
systems are also likely to be more evolvable [155]. Because of these extremely important
implications of degeneracy, it is a very useful concept for studying functional consequences
of crosstalk between signaling pathways.
Mathematical theory to study degeneracy in differential systems has recently been de-
veloped [78]. Using those results we have studied the implications of ROS mediated
crosstalk between distinct signaling pathways. It was found that in the presence of ROS
mediated crosstalk between the IL-4 and Epo pathways, the system exhibited positive de-
generacy. Abolishing this crosstalk reduced degeneracy drastically. At the same time, a
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complex but redundant network was found to have lower degeneracy than a non-redundant
one. The most direct interpretation of these results is that ROS mediated crosstalk can in-
crease the degeneracy of a biological network by interfacing otherwise separate signaling
modules. If the implications of degeneracy highlighted above are also taken into considera-
tion, by association, ROS mediated crosstalk could be functionally important in conferring
very important properties like robustness and evolvability to the network. As suggested in
[51], the requirements of robustness and evolvability could be reconciled by having func-
tionally robust modules, but allowing easily adjustable interactions between the modules
to allow for evolvability. ROS mediated crosstalk can very effectively satisfy these crite-
ria — enzymatic regulation of distinct signaling pathways can keep them modular and the
promiscuous reactivity of ROS could be the flexible link connecting these pathways. In
their explanation of how ROS signaling could have evolved to become an important reg-
ulatory mechanism, Mittler et al. propose that ROS production mechanisms could have
evolved to act as a flexible link between functional modules, for example to facilitate com-
munication between cells (cells being the modules here) [90].
From a more practical standpoint, quantitative measures of degeneracy conferred on a
network by ROS mediated crosstalk could be important in the search for the right way to
utilize antioxidant therapy. By definition, degeneracy is a measure of how well distinct
modules can perform the same function, or in other words, compensate for each other.
Therapeutic strategies that target specific nodes in a network without effectively lowering
system degeneracy could fail because of the compensatory behavior of modules. There-
fore, degeneracy also gives a useful way to think about and optimize targeted therapeutic
approaches.
Results from simplified models of crosstalk between IL-4 and Epo signaling pathways
suggest that ROS could be an important vehicle for integrating these pathways. The notion
of degeneracy was used as a way to quantify ROS mediated functional integration between
the distinct signaling modules. Biologically meaningful implications of degeneracy suggest
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CONCLUSIONS AND FUTURE DIRECTIONS
6.1 Modeling complements experimentation generating new insights into
redox regulation
An array of complex regulatory mechanisms is responsible for controlling the dynamics
of cell signaling in mammalian cells, and ROS-mediated regulation has emerged as an-
other layer of control in signaling pathways. Since ROS are thought to cause or aggravate
a number of pathologies, a mechanistic understanding of how redox signaling operates is
very important. Acknowledging the fact that redox regulatory mechanisms do not oper-
ate in isolation, but richly interact with redox independent mechanisms, it is crucial that a
systems perspective be employed to study these interactions. While ROS affect the dynam-
ics of phosphorylation and dephosphorylation in signaling pathways, their mode of action
is quite distinct from kinases and phosphatases, which are the primary determinants of
phosphorylation dynamics. In particular, unlike the kinase and phosphatase enzymes, the
targets of ROS are a lot less precisely defined. To further complicate matters, experimental
methods to detect redox modifications of proteins are still evolving and remain qualita-
tive in nature. Therefore the challenge of understanding redox regulation in cell signaling
is three-fold – i) the need for integrative analysis of redox regulation; ii) the difficulty of
confidently knowing a priori the targets of redox regulation in a given signaling pathway;
and iii) the inability to experimentally interrogate, with quantitative accuracy, oxidative
modifications of proteins.
In the face of these daunting challenges, this dissertation set out to enhance the un-
derstanding of redox regulation of cell signaling using the IL-4 pathway as a model sys-
tem. It was hypothesized that mathematical and computational tools could be leveraged to
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draw inferences about the hidden modes of redox regulation in IL-4 signaling using exper-
imental data that is not directly indicative of protein oxidation dynamics. Collectively, the
results provide strong support to this hypothesis as a detailed model of regulation in the
IL-4 pathway was developed using only total and phosphorylated protein time courses, and
predictions of the model under extreme redox conditions were experimentally validated.
6.2 Phosphatase oxidation is an important motif in redox regulation
Computational models trained using experimental data were used to study redox regula-
tion in two different signaling systems. While the primary focus of this work was the IL-4
pathway, redox regulation in the MAP kinase cascade was also briefly examined. When
modeling the MAP kinase cascade, attention was focused on assessing the importance of
differential rates of oxidative phosphatase inactivation across the three tiers of the MAP
kinase cascade. Analysis of this model indicated that different, but finely-tuned rates of
phosphatase oxidation at each level of the cascade could explain the experimental observa-
tions.
In the case of the IL-4 pathway, the possibilities of redox regulation were examined
more exhaustively. Three different mechanisms of redox regulation, namely, i) PTP oxi-
dation; ii) JAK oxidation; and iii) ROS dependent redistribution of phosphatase between
subcellular compartments, were examined. Reduced representations of the IL-4 signaling
system were used to extensively test 16 alternate model topologies. The characteristic, slow
oscillation of pSTAT6 observed in experiments proved to be a very powerful discrimina-
tor of candidate models. One of the simplest models, one that used PTP oxidation as the
only mode of redox regulation, outcompeted all alternative models in qualitative as well
as quantitative interpretation of results. Importantly, accounting for interactions between
ROS dependent and independent mechanisms was also found to be essential in correctly
inferring the effects of redox regulation. In contrast with the MAP kinase model, differen-
tial redox sensitivity across the phosphatases (there were two different phosphatases in the
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model) was not found to be essential.
Both models demonstrate the power of mathematical modeling for testing alternative
hypotheses and understanding the underlying architecture of biological networks, therein
providing support to the central hypothesis of this work. Results from the analysis of
the IL-4 pathway additionally highlight the value of modeling small sub-networks to gain
meaningful biological insights.
The two models are also similar in suggesting that phosphatase oxidation is an impor-
tant mechanism of redox regulation. This is an important result because the same regulatory
motif, i.e., reversible oxidative inactivation of phosphatases, was instrumental in explaining
and predicting the behavior of two signaling systems with very different topologies. Taken
together with the fact that both the signaling pathways studied are representatives of larger
“families” of signaling pathways, it is very likely that phosphatase oxidation is used as a
common design principle across a number of signaling pathways.
6.3 ROS as mediators of pathway crosstalk
As highlighted above, the action of ROS on proteins is distinct from that of enzymes be-
cause freely diffusing ROS can react relatively non-specifically with any accessible protein
susceptible enough to oxidation. Moreover, the components of separate signaling modules
may not always be spatially segregated in a cell, for example two phosphatases regulating
two separate pathways may both be distributed similarly in the cytosol. If these two phos-
phatases were to be equally sensitive to oxidation, it follows that ROS coming from any
source would equally affect both the phosphatases, and hence the signaling pathways they
regulate. The ability of ROS to mediate crosstalk was examined using the framework of
degeneracy — the ability of structurally distinct modules to perform identical function.
Using previously established mathematical definition of degeneracy for differential sys-
tems [78], it was found that ROS mediated crosstalk indeed resulted in increased degener-
acy in the crosstalking IL-4 and Epo pathways. Degeneracy has been argued to be related
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to other properties of biological systems like robustness and evolvability. The divergent re-
quirements of robustness and evolvability could be satisfied by having functionally robust
modules with easily evolvable links between them. In this way the modules are resistant to
perturbation but at a higher level, the system can evolve by changing connections between
modules. It is possible that non-specific ROS mediated cross talk acts as this flexible link
between robust signaling modules. Altering the mechanism of activation or subcellular lo-
calization of one ROS producing enzyme to alter the connections between ROS-sensitive
modules is easier than successfully re-tuning all components of complex signaling mod-
ules. Multiple NOX enzymes localized in different subcellular compartments and regulated
by different mechanisms could have evolved in this manner.
As argued in Chapter 5, degeneracy introduced by ROS could also lead to compensatory
behaviors between signaling pathways and this could have important implications for the
outcome of targeted therapeutic strategies.
6.4 Development of new computational tools
New computational tools have been developed to study the biological questions that were
the focus of this dissertation. A novel restart strategy for use with the evolutionary strat-
egy algorithm, named ES with hyper-mutation (Chapter 4), was developed to support the
need for parameter estimation in the models. An innovative model selection strategy based
on qualitative matching of simulation output with experimental data was successfully em-
ployed. Of course, the success of this method was contingent on the characteristic dy-
namics of STAT6 phosphorylation (Chapter 3). This result suggests that when distinctive
features are presented by experimental data, the qualitative ability of a model to reproduce
those features can be an effective discrimination tool. Finally, a detailed model of the IL-4
pathway was developed by building in known mechanisms of regulation in the pathway to-
gether with ROS dependent mechanisms. Two predictions of this model were successfully
validated by experimental results. Other falsifiable predictions can be generated and used
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to refine the model to build a more comprehensive understanding of the IL-4 pathway.
6.5 Future directions
6.5.1 Alternative patterns of distribution of redox control
Although the models of redox regulation developed in this work provide satisfactory ex-
planation of the data currently available, several simplifying assumptions have been made
whose validity needs to be checked. In the MAPK model as well as the IL-4 model, a one-
to-one correspondence was assumed between phosphatases and their substrates. Based on
experimental evidence, one substrate could have multiple phosphatases, and the total activ-
ity of one phosphatase could be distributed over multiple substrates. Moreover, subcellular
localizations of these phosphatases may be distinct and their reactivities to ROS may vary.
Different patterns of distribution of phosphatase activity between substrates and varying
reactivities to ROS are likely to affect the dynamics of signaling.
While these points are challenging to explore through experimental methods, hypothet-
ical models derived from the one already constructed could be a good starting point to
explore these alternatives. Interesting scenarios suggested by these simulations could be
specifically selected for experimental investigation.
In the context of the MAPK cascade, only phosphatase oxidation was explored as the
possible mechanism of redox regulation. Recently, oxidative activation of receptor tyrosine
kinase has been reported [104] and would be an interesting point to explore through model-
based simulations.
6.5.2 Mechanisms of protein oxidation and reduction
How sufficient ROS can be generated to substantially oxidize proteins is an open question.
Locally elevated ROS concentrations [158] and the use of relay proteins [44] to efficiently
transfer oxidative state have been suggested as possible mechanisms. These mechanisms
could be explored using the IL-4 model. While partial differential equation based descrip-
tions may be appropriate to explore the spatio-temporal effects of ROS distribution on cell
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signaling, simplified spatio-temporal representations can be generated using ODEs. For
example, the cytosol could be divided into two sub-compartments – one cell membrane-
proximal with higher ROS due to proximity with, say NOX1; the other membrane-distal
with lower ROS concentration. Signaling proteins, which could have different distribu-
tions between these compartments, would be differently affected by ROS. Implementing
oxidation state relays is a relatively simple process and could be explored more easily.
The model also assumes steady availability of enzymes to reduce the oxidized phos-
phatases. Because receptor activation causes transient change in intracellular redox state,
the buffering capacity of the cell can be expected to change dynamically. A more faithful
implementation of this phenomenon in the model may be desirable.
6.5.3 Role of nuclear-cytosolic shuttling of STAT6
The model predicts that phosphorylation dependent nuclear-cytosolic shuttling of STAT6 is
an important mechanism of redox regulation in the pathway. Pharmacological inhibitors of
nuclear import or export could be used to test this prediction of the model. However, phar-
macological inhibition will also simultaneously affect the nuclear-cytosolic distribution of
the phosphatases of STAT6. An alternative approach could be to separate out nuclear and
cytosolic fractions of pSTAT6 experimentally in order to falsify and improve the model.
6.5.4 Testing mechanisms of ROS mediated crosstalk
ROS mediated crosstalk was found to enhance system degeneracy, which could have many
important biological implications as discussed in Chapter 5. However, the question that
remains unanswered is that how is specificity of response maintained in the face of a non-
specific second messenger, like H2O2. The findings of this dissertation do not address this
question and concerted modeling and experimental efforts will be required in the future to
find a satisfactory answer.
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APPENDIX A
DETAILS OF THE MAP KINASE MODELS
Details of implementation of all models used in Chapter 2 are given here.
A.1 The base model
The equations and parameter values for the model used in Fig. 2b (referred to as the base
model) are presented below. The model was adopted from the Raf/MEK/ERK module of
the model in [124].
Table 3: Equations of the base MAPK model
Reaction Rate equation
Raf + RasGTP↔ [Raf:RasGTP] k1×Raf×RasGTP − k_1×[Raf:RasGTP]
[Raf:RasGTP]→ [Raf*] + RasGTP k2×[Raf:RasGTP]
MEK + [Raf*]↔ [MEK:Raf*] k3×MEK×[Raf*] − k_3×[MEK:Raf*]
[MEK:Raf*]→MEKp + [Raf*] k4×[MEK:Raf*]
MEKp + [Raf*]↔ [MEKp:Raf*] k5×MEKp×[Raf*] − k_5×[MEKp:Raf*]
[MEKp:Raf*]→ [MEK*] + [Raf*] k6×[MEKp:Raf*]
ERK + [MEK*]↔ [ERK:MEK*] k7×ERK×[MEK*] − k_7×[ERK:MEK*]
[ERK:MEK*]→ ERKp + [MEK*] k8×[ERK:MEK*]
ERKp + [MEK*]↔ [ERKp:MEK*] k9×ERKp×[MEK*] − k_9×[ERKp:MEK*]
[ERKp:MEK*]→ [ERK*] + [MEK*] k10×[ERKp:MEK*]
[Raf*] + P1↔ [Raf*:P1] k11×[Raf*]×P1 − k_11×[Raf*:P1]
[Raf*:P1]→ Raf + P1 k12×[Raf*:P1]
Continued on next page
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Table3 – continued from previous page
Reaction Rate equation
[MEK*] + P2↔ [MEK*:P2] k13×[MEK*]×P2 − k_13×[MEK*:P2]
[MEK*:P2]→MEKp + P2 k14×[MEK*:P2]
MEKp + P2↔ [MEKp:P2] k15×MEKp×P2 − k_15×[MEKp:P2]
[MEKp:P2]→MEK + P2 k16×[MEKp:P2]
[ERK*] + P3↔ [ERK*:P3] k17×[ERK*]×P3 − k_17×[ERK*:P3]
[ERK*:P3]→ ERKp + P3 k18×[ERK*:P3]
ERKp + P3↔ [ERKp:P3] k19×ERKp×P3 − k_19×[ERKp:P3]
[ERKp:P3]→ ERK + P3 k20×[ERKp:P3]
P1 + H2O2→ P1ox k21×P1×H2O2
P2 + H2O2→ P2ox k22×P2×H2O2
P3 + H2O2→ P3ox k23×P3×H2O2
P1ox → P1 k24×P1ox
P2ox → P2 k25×P2ox








H2O2 = a*exp( − ( (time−b)/c )2 ) * (1 + erf(d*time))
A.1.2 Outputs
Total ERKpp = [ERK*] + [ERK*:P3]
Total phospho MEK = [MEK*] + [MEK*:P2] + [ERK:MEK*] + [ERKp:MEK*] + MEKp
+ [MEKp:P2] + [MEKp:Raf*]
A.1.3 Parameter values
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Table 5: Non-zero initial values in the base model








A.2 Simulation of other experimental conditions in Fig. 2
A.2.1 Catalase pretreatment
This was simulated by setting a = 0 in the base model resulting in 0 H2O2 over time.
A.2.2 H2O2 bolus addition
The H2O2 input function was disabled in the base model and the following reaction was
added to the system.
H2O2 → null, rate = k27× H2O2
k27 = 0.09 min−1 and initial value of H2O2 was 4.5×104.
A.3 Nuclear shuttling model
The following reactions were added to the base model to obtain the nuclear shuttling model
in Fig. 4.
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Table 6: Equations of the nuclear shuttling model
Reaction Rate
ERK↔ ERKn kcyt2nuc×ERK − knuc2cyt×ERKn
ERKp↔ ERKpn kcyt2nuc×ERKp − knuc2cyt×ERKpn
[ERK*]↔ [ERK*n] kcyt2nuc×[ERK*] − knuc2cyt×[ERK*n]
P3↔ P3n kcyt2nuc×P3 − knuc2cyt×P3n
P3ox ↔ P3ox,n kcyt2nuc×P3ox − knuc2cyt×P3ox,n
P3ox,n → P3n k26×P3ox,n
[ERK*n] + P3n ↔ [ERK*n:P3n] k17×[ERK*n ] × P3n − k_17 × [ERK*n:P3n]
[ERK*n:P3n]→ ERKpn + P3n k18×[ERK*n:P3n]
ERKpn + P3n ↔ [ERKpn:P3n] k19×ERKpn×P3n − k_19×[ERKpn:P3n]
[ERKpn:P3n]→ ERKn + P3n k20×[ERKpn:P3n]
The subscript ‘n’ denotes nuclear concenration and the subscript ‘ox’ indicates oxidized
protein. The new parameters introduced were taken to be kcyt2nuc = knuc2cyt = 1/min.
A.4 Kinase oxidation model
The following additional reactions were added to the base model.
Table 7: Additional reaction of the kinase oxidation model
Reaction Rate
[ERK*] + H2O2→ [ERK*ox] k27×[ERK*]×H2O2
[ERK*ox]→ [ERK*] k28×[ERK*ox]
The subscript ‘ox’ denotes oxidized protein. The new parameters introduced are k27 =
5 × 10−3/(µM.min) and k28 = 5 × 10−2/min.
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A.5 Akt-ERK crosstalk model
Equations for the Akt-ERK crosstalk model are presented below. The model, along with
the symbols for molecules and complexes, was adopted from [52].
A.5.1 Reactions
Table 8: Equations of the Akt-ERK crosstalk model
Reaction Rate
R + HRG↔ [R:HRG] k1 × R × HRG − k_1 × [R:HRG]
2 [R:HRG]↔ [(R:HRG)2] k2 × [R:HRG]2 − k_2 × [(R:HRG)2]
[(R:HRG)2]↔ RP k3 × [(R:HRG)2] − k_3 × RP
RP→ [(R:HRG)2] V4×RPK4+RP
RP + Shc↔ [R-Shc] k5 × RP × Shc − k_5 × [R-Shc]
[R-Shc]↔ [R-ShP] k6 × [R-Shc] − k_6 × [R-ShP]
[R-ShP] + GS↔ [R-ShGS] k7 × [R-ShP] × GS − k_7 × [R-ShGS]
[R-ShGS]↔ RP + ShGS k8 × [R-ShGS] − k_8 × RP × ShGS
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RP + PI3K↔ [R-PI3K] k23 × RP × PI3K − k_23 × [R-PI3K]
[R-PI3K]↔ [R-PI3K*] k24 × [R-PI3K] − k_24 × [R-PI3K*]









RP→ null k34 × RP
PP2A + H2O2→ PP2Aox k35 × PP2A × H2O2
PP2Aox → PP2A k36 × PP2Aox
Raf→ [Raf*] k37×PP2A×RafK37+Raf
MKP3 + H2O2→MKP3ox k38 ×MKP3 × H2O2
MKP3ox →MKP3 k39 ×MKP3ox
The subscript ‘ox’ represents oxidized protein.
92
A.5.2 Parameters
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Species with non-zero initial values are listed below.
Table 10: Non-zeros initial values of the Akt-ERK crosstalk
model
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Fig. 6c was obtained by making the following modifications to the above model
K14b = 0.1, k14b = 4.038, K18 = 500.
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APPENDIX B
DETAILS OF ANALYSIS OF THE IL-4 PATHWAY
Implementation details of models used in Chapter 3 are provided in this Appendix.
B.1 Model used for Monte Carlo simulations
ODE system representing the reduced model used for MC Simulations is given below. The
quantities represented by the variables are shown in Table 11 and Table 13.
ẋ(1) = −k(1) × x(1) × x(3) + k(2) × x(2) − k(11) × x(1) × x(10) + k(12) × x(12)
ẋ(2) = +k(1) × x(1) × x(3) − k(2) × x(2)
ẋ(3) = −k(3) × x(3)
ẋ(4) = −k(4) × x(4) × x(2) + k(5) × x(5) × x(8) + k(7) × x(7) − k(6) × x(4)
ẋ(5) = +k(4) × x(4) × x(2) − k(5) × x(5) × x(8) − k(6) × x(5) + k(7) × x(6)
ẋ(6) = +k(6) × x(5) − k(5) × x(6) × x(9) − k(7) × x(6)
ẋ(7) = +k(5) × x(6) × x(9) − k(7) × x(7) + k(6) × x(4)
ẋ(8) = −k(6) × x(8) + k(8) × x(9) × x(10) − k(11) × x(8) × x(10) + k(12) × x(11)
ẋ(9) = +k(6) × x(8) − k(8) × x(9) × x(10)
ẋ(10) = +k(9) × x(2) − k(10) × x(10)
ẋ(11) = +k(11) × x(8) × x(10) − k(12) × x(11)
ẋ(12) = +k(11) × x(1) × x(10) − k(12) × x(12)
This ODE system represents the largest possible model with all regulatory mechanism
shown in Fig. 9 operating in parallel. To simulate the other models, terms were removed
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from this model accordingly. The meanings of the symbols are as follows.
B.1.1 Species















The names of molecules in the right hand column correspond to the names used in Fig. 9
After setting up the ODE system, parameters were sampled uniformly in the log space
in the ranges given Table 12 and Table 13. The system was allowed to equilibrate before




Initial values of the following species were non-zero at the beginning. The ranges in which
values were sampled are shown.
Table 12: Sampling ranges of initial values for MC simula-
tions





Rate constants were sampled from the ranges specified below.
Table 13: Sampling ranges of rate constants for MC simula-
tions
Symbol Lower bound Upper bound Description
k(1) 0.8 8 Receptor activation
k(2) 0.1 1 Receptor inactivatin
k(3) 0.08 0.8 IL-4 removal
k(4) 1 10 STAT activation
k(5) 0.01 0.1 STAT inactivation
k(6) 0.08 0.8 Nuclear translocation rate
k(7) 0.08 0.8 Cytosolic translocation rate
k(8) 0.3 3 ROS production rate
k(9) 0.01 0.1 ROS removal rate
Continued on next page
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Symbol Lower bound Upper bound Description
k(10) 0.8 8 Protein oxidation rate
k(11) 0.0001 0.001 Protein reduction rate
k(12) 5 50 ROS mediated PTP translocation
B.2 Systems level model of the IL-4 pathway
The biochemical reactions modeled in the network shown in Fig. 13 are presented here.
Descriptive names have been used for rate constants and molecular species to clarify their
meaning.
Table 14: Equations of the IL-4 system model
Reaction Rate
R + L↔ RL kRLBind×R×L − kRLUnbind×RL
RL→ Ract kRact×RL
Ract + Stat↔ StatRact kStatRBind×Ract×Stat − kStatRUnbind×StatRact
StatRact→ Statp + Ract kStatPhos×StatRact
2Statp↔ StatAct kStatDimerize×Statp×Statp − kStatDissoc×StatAct
StatAct→ StatActNuc kcyt2nuc×StatAct
StatActNuc + P1n ↔
P1nStatActNuc
kPTPBind×StatActNuc×P1n − kPTPUnbind×P1nStatActNuc




Ract + P2↔ RactP2 kPTPBind×Ract×P2 − kPTPUnbind×RactP2
RactP2→ RL + P2 kcatPTP×RactP2
P1 + StatAct↔ StatActP1 kPTPBind×P1×StatAct − kPTPUnbind×StatActP1
StatActP1→ Stat + Statp + P1 kcatPTP×StatActP1
P1 + Statp↔ StatpP1 kPTPBind×P1×Statp − kPTPUnbind×StatpP1
Continued on next page
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Reaction Rate
StatpP1→ Stat + P1 kcatPTP×StatpP1
StatActNuc→ StatActNuc + Socs vmTrans×StatActNucKmTrans+StatActNuc
Ract + Socs↔ RactSocs RSocsBind×Ract×Socs − RSocsUnbind×RactSocs
P2 + ROS→ P2ox koxPTP×P2×ROS
P2ox→ P2 kredPTP×P2ox
P1 + ROS→ P1ox koxPTP×P1×ROS
P1ox→ P1 kredPTP×P1ox
Ract→ null kintRAct×Ract
null↔ Stat ksynthStat − kdegStat×Stat
Socs→ null kdegSocs×Socs
RactSocs + P2↔ RactSocsP2 kPTPBind×RactSocs×P2 − kPTPUnbind×RactSocsP2
RactSocsP2→ RL + P2 + Socs kcatPTP×RactSocsP2
StatpNuc + P1n↔ P1nStatpNuc kPTPBind×StatpNuc×P1n − kPTPUnbind×P1nStatpNuc
P1nStatpNuc→ StatNuc + P1n kcatPTP×P1nStatpNuc
StatpNuc↔ StatActNuc kStatDimerize×StatpNuc×StatpNuc − kStatDissoc×StatActNuc
P1↔ P1n kcyt2nuc×P1 − knuc2cyt×P1n
P1ox↔ P1nox kcyt2nuc×P1ox − knuc2cyt×P1nox
P1nox→ P1n kredPTP×P1nox
B.2.1 Optimized Parameters
Concentrations and rate constants were estimated to fit the model to experimental data. Be-
cause MG132 and CHX are both pharmacological inhibitors that affect protein degradation
and synthesis in the cell, some initial values had to be recalibrated for MG132 and/or CHX
pretreatment. Recalibrated values are shown in columns 3 and 4 of the tables below. If
these columns are blank, no re-estimation of parameters was necessary. The values are in
units of nM.
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Table 15: Optimized non-zero initial values of the model
Molecule IL4 MG132 + IL4 CHX + IL4
R 40.5
Total STAT6 1016 882.5
pSTAT6 304.8 364.0
SOCS 18.5 1.5 2.4
P2 84
P1 990.5
The estimated values of rate constants are shown in the table below. MG132 inhibited
the rate of protein degradation by a factor of “mgFac” and CHX slowed down the rate of
protein synthesis by a factor of “chxFac”. First order rate constants are in min−1 and second
order in nM−1s−1.
Table 16: Optimized parameter values of the IL-4 model
across different experimental conditions









Continued on next page
103
Table16 – continued from previous page




















B.2.2 Normalization of model output
Simulated total concentrations of STAT6, pSTAT6 and SOCS were calculated by summing
together the time courses of all molecular complexes containing these species. Stoichiom-
etry of dimeric form of pSTAT6 was accounted for as shown in the equations below. The
variable names on the RHS correspond to names used in the equations in Table 14.
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pSTATtotal = 2 × StatAct + 2 × StatActNuc + Statp + 2 × StatActPTP1B + StatpPTP1B
+ 2 × TCPTPStatActNuc + StatpNuc + TCPTPStatpNuc
STATtotal = Stat + Statp + 2 × StatAct + 2 × StatActNuc + StatNuc + 2 × StatActPTP1B
+ StatpPTP1B + 2 × TCPTPStatActNuc + StatRact + StatpNuc
+ TCPTPStatpNuc
SOCStotal = Socs + RactSocs + RactSocsCD45
To compare model output with experimentally measured protein fluorescence, all model
output was normalized using an equation of the form y(t) = a × x(t) + b, where x(t) is the
simulated time course and a and b are molecule specific, optimized constants. Values of a
and b for all three experimentally measured species are given in the table below.
Table 17: Normalization factors for simulation output
Molecule a b
Total STAT .001 .063
SOCS3 .0133 1.0372
pSTAT6 0.0033 0
B.2.3 ROS input to the model
Experimentally measured intracellular oxidation of Jurkat cells under IL-4 stimulation was
used as a direct input to the model. h(t), the time derivative of Hill equation fitted to CM-
H2DCFDA oxidation data (Fig. 7) is given by
h(t) =
1.25 × 106 × t1.5
(4725 + t2.5)2
(3)
To reflect the basal oxidation state of the cell and to scale the numerical value of curve
to a reasonable level, the, intracellular ROS were assumed to follow the equation
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ROS(t) = rosBaseline + rosScale × h(t)
These parameters rosBaseline and rosScale were optimized to values shown in Table 16.
The curve corresponding to the DPI pretreated cells is given by
hDPI(t) =
8.3 × 105 × t1.5
(8738 + t2.5)2
When validating the model with DPI data, rosBaseline was assumed to be 0 and rosS-
caleDPI was chosen to be a tenth of rosScale. These numbers were chosen to reflect the
highly reduced state of the cell under DPI treatment. Also, since the initial phosphorylation
of STAT6 was drastically reduced under the influence of DPI, to simulate DPI prereatment,
low initial phosphorylation of STAT6 (5% of total STAT6) was assumed.
To simulate exogenous addition of H2O2 together with IL-4 stimulation, an exponen-
tially decaying curve was added to Eq. (3). The rate of decay was adjusted so that ROS
were brought back to baseline level in approximately 20 min. The following equation was
used to simulate the combined effect of H2O2 and IL-4:
ROS(t) = rosBaseline + rosScale × (h(t) + 1000 × exp(−0.3 ∗ t))
B.3 Optimization of cell concentration and serum starvation period
The cell concentration and serum starvation period to be used in the experiments for mea-
suring STAT6 phosphorylation were optimized to maximize the pSTAT6 signal. The serum
starvation condition was first optimized by testing a range of values and 4 hours of serum
starvation was found to be nearly optimal for maximizing pSTAT6 (Fig. 24). Cell con-
centration of 16 × 106 cells/ml was used for the experiments performed to optimize the
starvation period. Next, the optimal cell concentration was determined by testing a number
of cell concentrations with 4 hours of serum starvation, and a concentration of 4 × 106 was
found to be nearly optimal (Fig. 25).
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Figure 24: Optimization of serum starvation period. Jurkat cells were serum starved by
culturing them at 16 × 106 cells/ml in Jurkat media with 0.5% FBS for a range of time
periods. The serum starved cells were stimulated with 100 ng/ml IL-4 for 20 min and
pSTAT6 was quantified using flow cytometry.


















Figure 25: Optimization of cell concentration. Jurkat cells at different concentrations
were serum starved for 4 hours. The serum starved cells were stimulated with 100 ng/ml
IL-4 for 20 min and pSTAT6 was quantified using flow cytometry.
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Figure 26: Histone staining in permeabilized Jurkat cells. Jurkat cells were permeabilized
or not and stained for the nuclear protein histone. Permeabilized and stained cells (blue
histogram) showed signal well above background (red) suggesting that the permeabilization
protocol made the intra-nuclear space accessible to the staining antibodies.
B.4 Experimentally measured pSTAT6 represents whole cell value
We have based much of our analysis of the IL-4 pathway on our ability to measure total
pSTAT6 levels in the cell. To verify that we were indeed measuring whole cell pSTAT6
through our flow cytometry protocol, we performed two separate experiments.
B.4.1 Histone staining to verify that the nuclear compartment is accessible
Jurkat cells were serum starved like in other experiments (see Methods in Chapter 3).
Serum starved cells were either fixed, and then permeabilized or not. Cells were then
stained for the nuclear protein, histone. Only cells that were permeabilized showed a posi-
tive signal above background. Representative data are shown in Fig. 26. This suggests that
the permeabilization protocol was sufficient to allow antibodies access to the nucleus.
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Figure 27: Confocal microscope images confirm whole cell distribution of pSTAT6. Ju-
rkat cells permeabilized and statined for pSTAT6 were counterstained with DAPI. pSTAT6
was found to be distributed throught the intracellular space.
B.4.2 Confocal microsocopy of pSTAT6 stained cells
Jurkat cells were permeabilized and stained for pSTAT6 following the protocol used in
other experiments (Methods in Chapter 3). The nucleus was costained with DAPI. Cells
were observed under a confocal microscope and it was found that DAPI stain localized to
the nucleus whereas pSTAT6 could be detected in both the nuclear and cytosolic compart-
ments Fig. 27
B.5 J45.01 cells to validate the IL-4 model
We attempted to validate the model using data from the J45.01 cell line, which is derived
from Jurkat cells by exposing them to gamma irradiation and selecting CD45 deficient
cells. Since CD45 is a phosphatase involved in regulation of IL-4 signaling, we hypoth-
esized that signaling characteristics of Jurkat and J45.01 should be different, and these
differences should be determined by the differential expression of CD45 between the two
cell lines. If this hypothesis is correct, the behavior of J45.01 cells could be simulated in the
systems model of IL-4 pathway by assuming reduced concentration of membrane bound
PTP, providing a way to further validate the model. We performed experiments using the
J45.01 cell line with a view to acquire data that could be used to validate the model.
109
















Figure 28: STAT6 phosphorylation following IL-4 stimulation of J45.01 cells. J45.01
cells were serum starved for 4 hours and stimulated with 100 ng/ml IL-4. pSTAT6 was
quantified using flow cytometry. Mean and standard errors are shown; n = 4.
B.5.1 J45.01 cells do not respond to IL-4 stimulation
We measured STAT6 phosphorylation in J45.01 cells following IL-4 stimulation and found
that basal level of pSTAT6 in this cell line was more than 5 fold higher than that observed
in Jurkat cells (compare Fig. 28 with Fig. 7). Furthermore, IL-4 stimulation did not alter
pSTAT6 level significantly compared to baseline (Fig. 28). When the J45.01 cells were
treated with DPI, STAT6 phosphorylation steadily decreased over time but even under this
condition, IL-4 did not elicit any increase in pSTAT6 as compared to cells untreated with
IL-4 (Fig. 29).
We hypothesized that the non-responsiveness of J45.01 cells to IL-4 could be linked to
altered dynamics of ROS production in these cells as compared to Jurkat cells. To test this
hypothesis we measured oxidation of CM-H2DCFDA in J45.01 following IL-4 stimulation.
In a manner similar to pSTAT6, the oxidation of CM-H2DCFDA did not change signifi-
cantly when J45.01 cells were stimulated with IL-4 (Fig. 30); however, unlike pSTAT6, the
basal oxidation CM-H2DCFDA observed in J45.01 cells was very similar to that found in
Jurkat cells. This suggests that high basal level of STAT6 phosphorylation in J45.01 cells
is probably not linked to cellular oxidation state.
110















Figure 29: Effect of DPI on IL-4 signaling in J45.01 cells. J45.01 cells were serum
starved for 4 hours and treated with DPI for 1 hour before being stimulated with 100 ng/ml
IL-4. pSTAT6 was quantified using flow cytometry. Mean and standard errors are shown;
n = 4.

























Figure 30: Intracellular oxidation in J45.01 cells following IL-4 stimulation. J45.01 cells
were incubated with CM-H2DCFDA for 30 minutes prior to IL-4 stimulation and oxida-
tion of CM-H2DCFDA was measured using flow cytometry. Mean and standard errors are

























Figure 31: Dose-response of Jurkat and J45.01 cells to IL-4. Jurkat and J45.01 cells were
serum starved for 4 hours separately and treated with different concentrations of IL-4 for
15 minutes. STAT6 phosphorylation was measured using flow cytometry.
One of the possible reasons for the lack of response to IL-4 could be that J45.01 cells
require stronger IL-4 stimulation than Jurkat cells. To rule out the possibility that the IL-4
concentration was too low for J45.01 cells, we measured the dose responsiveness of J45.01
and Jurkat cells. We found that while STAT6 phosphorylation in Jurkats increased with
increasing IL-4, the dose-response curve for J45.01 cells was flat, indicating that J45.01
cells failed to respond to IL-4 over a wide range of doses (Fig. 31).
The lack of responsiveness of J45.01 cells over a wide range of IL-4 doses is indicative
of missing components of the IL-4 signaling pathway. We tested J45.01 cells for the pres-
ence of IL-4 receptor alpha and found that the expression was comparable between Jurkat
and J45.01 cells (Fig. 32).
B.5.2 Expression of multiple proteins could be perturbed in J45.01 cells
We next hypothesized that the difference in pSTAT6 levels between Jurkat and J45.01 cells
could be linked to different total STAT6 levels in the two cell lines. We quantified total
STAT6 in both cell lines and observed that the basal expression of total STAT6 was nearly
1.6 times greater in J45.01 cells (Fig. 33). The greater levels of pSTAT6 in J45.01 cells
















Figure 32: Expression of IL-4 receptor alpha in Jurkat and J45.01 cells. Cells were

























Figure 33: J45.01 cells express more STAT6 than Jurkat cells. J45.01 and Jurkat cells
were separately serum starved for 4 hours and the basal expression of total STAT6 was
measured using flow cytometry. Data were normalized to get the MFI in Jurkat cells equal
to 1. Mean and standard errors are shown; n = 3.
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However, as compared to Jurkat cells, the basal STAT6 phosphorylation was more than 5
times greater in J45.01 cells, which is not proportional to the increase observed in total
STAT6 levels. The higher level of total STAT6 in J45.01 cells also indicates that CD45 is
not the only protein to be expressed differentially between the two cell lines. It is possible
that several other proteins have altered expression levels in J45.01 cells, which could affect
the dynamics of IL-4 signaling in unpredictable ways. Quantifying all such differences and
simulating them in our model of IL-4 signaling is a very difficult proposition. We therefore
decided not to use J45.01 cells to validate our model.
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APPENDIX C
ES-HM IMPLEMENTATION AND TESTING DETAILS
C.1 Test functions
The test functions used to evaluate the performance of the algorithms are described below.







• x ∈ [−100, 100]n
C.1.2 Schwefel’s problem 2.21
f2(x) = max{|xi|, 1 ≤ i ≤ n} (5)
• Unimodal, non-separable










• x ∈ [−5, 5]n
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C.1.4 Ackley function













 + 20 + e (7)
• Multimodal, separable





























• x ∈ [−600, 600]n
















1.1 + 8 ×
i − 2
19
, i = 2, . . . 21
10 , i = 1
• Ci = Λαi/α1/4i , where Λ




i and then randomly permuted. αis are in turn drawn with uniform random
chance from the set {10002 j/19 | j = 0, . . . , 19} without replacement for i = 1, . . . , 21,
and α1 = 10002.
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• R is an orthonormal (rotation) matrix. It was generated from a matrix with standard
normally distributed entries by QR decomposition using the Matlab function qr.
• For each run of f7, a new set of Ci and R was generated.
• yi are local optima chosen by uniform random sampling from [−4.9, 4.9]n for i =
2, . . . , 21. The global optimum y1 was uniformly randomly sampled in [−4, 4]n.
• f7 is multimodal with 21 optima with random sizes and positions.
• x ∈ [−5, 5]n























• Rugged landscape with non-unique global optimum
• x ∈ [−5, 5]n












• z = Rx, where R is a rotation matrix as defined in C.1.7








n + 20 − 8.2
, d = 1.
• Multimodal, non-separable
• Very rugged landscape superimposed on two larger valleys around µ0 and µ1. The
global optimum is at µ0.
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• x ∈ [−5, 5]n
C.2 Settings used in the ES algorithms
This section describes the details of the internal settings used in the implementation of the
evolutionary strategy algorithms. All the variants of ES used in the present work (ES, ES
with naive restart, ES-IPOP, ES-HM) were implemented by adding metaheuristics on top
of the same implementation of ES; therefore, the settings described here were common to
all algorithms. The symbols used are µ, the number of parents; λ, the number of offspring;
xi, object parameter vectors; and σi are the strategy parameters.
Initial population: Initial population was generated by uniform random sampling on
linear scale in the search range for all the test functions. For the ODE model, since the
parameter ranges spanned several order of magnitude, the initial population was sampled
uniformly on a log scale.
Initial step size: Initial step size for each parameter was set at 0.1 times the width of the
search range for the parameter.
Recombination: Global uniform recombination was used [125] to recombine the object
parameters as well as strategy parameters. For example, in a population of µ parents, there
are µ values of xi, the ith component of the object parameter vector , i = 1, . . . , n. To
generate a child using global uniform recombination, one of these µ different values of xi is
picked randomly for each i. This process is repeated λ times to get the offspring population.
The same process is applied to the strategy parameters.
Mutation: Mutation was applied to both object and strategy parameters using the fol-
lowing equations for i = 1, . . . , λ and j = 1, . . . , n [163].
σ′i j = σi j exp
(
τ′N(0, 1) + τN j(0, 1)
)
(13)
x′i j = xi j + σ
′
i jN j(0, 1) (14)
where, xi j and σi j are jth components of of the vectors xi and σi, respectively. The primed
symbols indicate the mutated values. The mutated step size is used to mutate the object
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parameters. N(0, 1) represents a normally distributed scalar with mean 0 and standard












Stopping criteria: A stopping criterion was deemed to be satisfied if any of the follow-
ing became true. b denotes fitness score of the fittest individual in the current generation
and w, the worst fitness score.
- |w − b| < absTolFitness
|w− b| < relTolFitness× fîtness, where fîtness is the average fitness of the population
- σi j < absTolStepSize for all i, j
- σi j < relTolStepSize × xi j for all i, j
The default values used for the tolerances were absTolFitness = 10−3, relTolFitness =
10−6, absTolStepSize = 10−3, and relTolStepSize = 10−6.
C.3 A model of the IL-4 pathway
C.3.1 Major assumptions of the model
This model is not the same as the systems model of IL-4 signaling proposed in Chapter 3.
This is instead a simplified model of the IL-4 pathway that was used only to test the per-
formance of the optimization algorithm.
The IL-4 receptor uses the kinase activity of JAK1 and JAK3 proteins for downstream
phosphorylation. As JAK1 and JAK3 have been shown to be constitutively associated with
the cytoplasmic chains of the IL-4 receptor [45], we did not explicitly model the JAK
proteins and treated the IL-4 receptor/JAK complex as a single molecule. Furthermore,
we ignored the multimeric nature of the IL-4 receptor and assumed that IL-4 activates the
receptor in a single step [77].
STAT6 is thought to homodimerize after it is phosphorylated [113]. We ignored the
dimerization in our model and assumed that monomeric pSTAT6 represents the entire
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pSTAT6 pool. We further assumed that the IL-4 receptor and STAT6 have distinct phos-
phatases. However, a single phosphatase can possibly act on multiple substrates and the
assumption of one substrate-one phosphatase is a simplification [120].
We assumed that total concentration of all the modeled molecules, except IL-4 and
ROS, remains constant over time. We assigned a first order removal term to IL-4 to simulate
receptor mediated internalization and degradation. ROS time course was simulated using
explicit functions of time and provided as input to the model (Fig. 34).
C.3.2 ODE system and simulation settings
The ODE system shown below was used to model the IL-4 pathway assuming mass action
kinetics. Meanings of the symbols and values of the parameters are given in Tables 18
and 19. We ran the model from time t = −1500 min to t = 0 min to allow the system
to reach a steady state (equilibration process). During this equilibration, ROS levels were
fixed to a constant baseline value shown in the table. DPI pre-treatment was simulated by
setting the ROS baseline value to 1 to reflect depleted intracellular ROS. Our experimental
data showed noticeable phosphorylation of STAT6 even without any IL-4 stimulation. In
order to capture this effect in the model, we assumed the presence of a constant weak
activating signal throughoutt the equilibration process. This was simulated by fixing IL-4
concentration to 0.005 nM from time t = −1500 min to t = 0 min (value fitted by hand).
At time t = 0 min, IL-4 concentration was increased to 5.8 nM (corresponding to 100
ng/mL IL-4 used in the experiments) and first order decay of IL-4 was allowed (as shown
in Fig. 19). ROS time course was simulated using the profiles shown in Fig. 34.
The experimental data used to optimize the model represent normalized fluorescence
intensities corresponding to total phosphorylated STAT6 in Jurkat cells. To compare the
simulated time courses with the experimental data, the simulated values of cytosolic and
nuclear pSTAT6 were summed and then transformed using the equation y = ax + b, where
y is the transformed value, x is the total pSTAT6 concentration returned by the model and a
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and b are constants. The values of a and b were determined by mapping the lowest value of
x to the lowest experimental data point and the highest value of x to the largest data point,
when both the simulation and the experimental data were taken from the IL-4 stimulation
condition (i.e., with no DPI pre-treatment). The same transformation was also applied to
scale the simulation results for DPI + IL-4 treatment. It should be noted that the values of
a and b change depending on the parameters of the ODE system.
dx1
dt
= −k1x1x3 + k2x2x8
dx2
dt






= −k4x4x2 + k5x5x10 + k7x7
dx5
dt
= +k4x4x2 − k5x5x10 − k6x5
dx6
dt
= +k6x5 − k5x6x12
dx7
dt
= +k5x6x12 − k7x7
dx8
dt
= −k8x8ros + k9x9
dx9
dt
= +k8x8ros − k9x9
dx10
dt
= −k10x10x14 + k11x11
dx11
dt
= +k10x10x14 − k11x11
dx12
dt
= −k10x12x15 + k12x13
dx13
dt
= +k10x12x15 − k12x13
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C.3.3 Parameter values
Even though different members of the JAK-STAT family are activated by different inter-
leukins, the core structure of JAK-STAT pathway is very similar across many types of
cytokines, such as IL-1 and IL-4. Because of this similarity, we used the parameter set
of a previously published model of IL-1 signaling as the basis for parameter estimation of
JAK-STAT core of the IL-4 pathway [161]. Starting from these values, we adjusted them
by hand to obtain reasonable fits to the data as determined by visual inspection (column Ini-
tial estimate in Tables 18 and 19). The optimization algorithms were executed to estimate
parameters within fixed bounds around these initial estimates. The optimized parameter
values corresponding to the median fitness scores found by ES and ES-HM are presented
in Tables 18 and 19.
C.4 Tables and Figures
Table 18: Initial values. Symbols used in the equations and
the molecular species they represent according to Fig. 19.
Hand-fitted values used as first guess for optimization are
shown in the column Initial estimate. Parameter estimates
corresponding to the median scores found by ES-HM and
ES when the search range was fixed 5-fold above and below
the first estimate values are shown under the columns ES-
HM and ES, respectively. All concentrations are in units of
nM.
Symbol Molecular species Initial estimate Optimized value
ES-HM ES
x1 IL4R 4.51 10.9 1.23
Continued on next page
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Table18 – continued from previous page
Symbol Molecular species Initial estimate Optimized value
ES-HM ES
x2 IL4R* 0 0 0
x3 IL4 0.005a - -
x4 STAT6 168 209 243
x5 pSTAT6 0 0 0
x6 pSTAT6n 0 0 0
x7 STAT6n 0 0 0
x8 P1red 41.1 24 25.1
x9 P1ox 0 0 0
x10 P2red 117 572 162
x11 P2ox 0 0 0
x12 P2nred 0.094 0.45 0.195
x13 P2nox 0 0 0
x14 ROS (basal) 1.9e3b 792 633
x15 ROSn (basal) 1.9e2c 79.2 63.3
a IL-4 was set to a low initial value to simulate a small activating signal during equilibration (see subsection
C.3.2). The same value was used in all simulations. To simulate addition of 100 ng/mL IL-4 (the experimental
concentration used), IL-4 was changed to 5.8 nM.
b ROS level was fixed to this value during equilibration. Afterwards, curves shown in Fig. 34 were used. To
simulate DPI pre-treatment, the baseline ROS level was set to 1.
c Nuclear ROS was assumed to be one-tenth of cytosolic ROS throughout all conditions and time points in
order to reflect the relatively more reduced environment of the nucleus.
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Table 19: Rate constants. Symbols used in the equations
and the rate constants they represent according to Fig. 19 in
the main text are indicated. The hand-fitted values used as
the first guess for optimization are shown in the column Ini-
tial estimate. Parameter values corresponding to the median
scores found by ES-HM and ES when the search range was
fixed 5-fold above and below the first estimate values are
shown under the columns ES-HM and ES, respectively. First
order rate constants are in units of min-1 and second order
rate constants in nM-1min-1.
Symbol Rate constant Initial estimate Optimized value
ES-HM ES
k1 kract 0.0254 0.113 0.0903
k2 krinact 0.0048 0.0087 0.0019
k3 kintil4 0.0795 0.162 0.303
k4 konstat 12 31.2 4.81
k5 koffstat 3.5 11.3 5.63
k6 kc2n 0.266 0.598 0.865
k7 kn2c 0.334 0.87 0.622
k8 k1ox 0.00361 0.00774 0.0102
k9 k1red 0.178 0.281 0.489
k10 k2ox 0.00633 0.0268 0.027
k11 k2red 0.0886 0.114 0.0303
k12 k2redn 7.22 36 35.6
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Figure 34: ROS profiles. Oxidation of CM-H2DCFDA was measured for 60 min fol-
lowing stimulation with IL-4 without (a) or with (b) DPI pre-treatment for 1 hour (data
points show mean ± standard error of the mean from 3 independent runs after background
subtraction). Hill curves were fitted (lines in a and b) to the means and extrapolated to 120
min. Since the oxidation of CM-H2DCFDA is irreversible, the oxidation time courses show
cumulative oxidation of the dye over time. To estimate instantaneous ROS levels, deriva-
tives of the Hill curves were calculated, scaled by a constant and shifted on the y-axis to
represent baseline ROS concentration. In the IL-4 treatement condition, the scaling factor
was estimated to be 1000 and the baseline value was estimated at 1900 by manual fitting
(c). For the DPI-pretreated condition, the values were 10 and 1 respectively (d).
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Figure 35: STAT6 phosphorylation time course. Jurkat cells pre-treated or not with DPI
were treated with 100 ng/mL IL-4 and STAT6 phosphorylation time courses were measured
over a 2 hour time period. Background signal was subtracted from the mean fluorescence
intensity values obtained using flow cytometry; the background subtracted values were
divided by the fluorescence intensity of cells stained for pSTAT6 without DPI and IL-4
treatment to obtain normalized MFI values. Data points show mean ± standard error of the
mean from 3 independent experiments.
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Figure 36: Parameter and score distribution. ES-HM algorithm was run using 9 pairs of
(φ, ρ) values to optimize the parameters of the IL-4 model. Parameter bounds were set at
1000-fold above and below the first estimate and 10 runs were executed for each (φ, ρ) pair.
Box plots showing distributions of all the parameters (a) and scores (b) corresponding to
all the pairs are shown. The parameter values have been scaled by dividing them by the
corresponding first estimate values.
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APPENDIX D
DETAILS OF IL-4–EPO CROSSTALK MODEL
Details of models used in Chapter 5 to study ROS mediated crosstalk between IL-4 and
Epo pathways are provided here.
The network shown in Fig. 37 was coded into an ODE system assuming mass action
kinetics(Eq. (15)). The parameters of the model were optimized to get a reasonable fit to
data available from the literature (Fig. 38). The model without crosstalk (Fig. 23b) was ob-
tained by setting the rate constants k8, k11, k13 and k14 to 0. The hypothetical redundant
model (Fig. 23c) was obtained by making the following modifications to the model shown
in Fig. 37: i) JAK3* catalyzed phosphorylation of STAT5 was added (k = 0.8); ii) JAK2*
catalyzed phosphorylation of STAT6 was added (k = 0.8); iii) PTP1B catalyzed dephos-
phorylation of STAT6 was turned off; iv) PTP1B catalyzed dephosphorylation of JAK3*
was added (k = 1.2).
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ODE system used to model the network in Fig. 37:
ẋ1 = k18 − k1 × x1 + k3 × x2
ẋ2 = k1 × x1 − k19 × x2 − k3 × x2
ẋ3 = k18 − k2 × x3 + k4 × x4
ẋ4 = k2 × x3 − k20 × x4 − k4 × x4
ẋ5 = −k5 × x5 × x2 + k7 × x6
ẋ6 = k5 × x5 × x2 − k7 × x6
ẋ7 = −k6 × x7 × x4 + k8 × x8 × x9
ẋ8 = k6 × x7 × x4 − k8 × x8 × x9
ẋ9 = −k16 × x9 × x15 + k17 × x10
ẋ10 = k16 × x9 × x15 − k17 × x10
ẋ11 = −k9 × x11 × x6 + k11 × x12 × x9 + k18
ẋ12 = k9 × x11 × x6 − k11 × x12 × x9 − k21 × x12
ẋ13 = k18 + k12 × x14 − k10 × x13 × x8
ẋ14 = −k22 × x14 − k12 × x14 + k10 × x13 × x8
ẋ15 = k13 × x2 + k14 × x4 − k15 × x15 − k16 × x9 × x15
(15)
Table 20: List of species in the model and their initial values.






Continued on next page
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Table20 – continued from previous page











Table 21: Optimized values of rate constants. Edges associ-
ated with the constants are indicated in Fig. 37. First order
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k12
Figure 37: Model of the IL4R and EpoR signaling cross-talk. The signaling system was
modeled by ODEs shown in Eq. (15). The parameters in Table 21 correspond to edges
indicated in the figure.





































Figure 38: Approximate fitting of the model to experimental data. The parameters in
Table 21 were optimized to generate reasonable fits to STAT5 and JAK2 phosphorylation
data obtained from [139].
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APPENDIX E
LISTING OF MATLAB IMPLEMENTATION OF ES-HM
E.1 ES-HM in Matlab
A Matlab implementation of the ES-HM algorithm is presented here.
1 % Author: Gaurav Dwivedi (g.dwivedi@gatech.edu)
% Date: October 22, 2013
function [optimParam , funEvalCount , bestScores , ↓
→ worstScores] = es(fitnessFn , nvar, lb, ub, ↓
→ userOptions)
%ES uses evolutionary strategies to find the minimum of a given function.
6 %Hypermutation can be optionally turned on to use the ES-HM algorithm. If
%a worker pool has been started using matlabpool , ES uses parfor to
%parallelize objective function evaluation.
%
%The ES algorithm was implemented as described by ’Evolution and Optimum
11 %Seeking’ by Hans-Paul Schwefel (1995) and ’Evolutionary Computation ’ by
%Xin Yao, Ch. 2 in Evolutionary Optimization , editors, Ruhul Sarker, Masoud
%Mohammadian & Xin Yao (2002).
%
%The hyper-mutation (HM) algorithm was developed by Gaurav Dwivedi and
16 %Melissa L. Kemp.
%






% OPTIMPARAM = Optimized parameter values. This is the parameter vector
%−−−−−−−−−−−−−→corresponding to the fittest individual in the last generation.
% FUNEVALCOUNT = Number of function evaluations.
26 % BESTSCORES = Vector containing best fitness score for each generation.
% WORSTSCORES = Vector containing worst fitness score for each generation.
%
% Required input parameters:
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% --------------------------
31 % FITNESSFN = Handle to fitness scoring function. Should return a scalar
% (fitness score) when a vector of length NVAR is passed. If parallel is
% set to 1 in USEROPTIONS , it should accept an MxNVAR matrix, where each
% row is a parameter vector and return a vector of scores of length M, with
% each element being the fitness score corresponding to a row of the input ↓
→ matrix.
36 % NVAR = Problem dimension (i.e., number of object parameters to be
% optimized).
%
% Optional input parameters:
% --------------------------
41 % LB = Lower bound of parameters. If scalar, same lower bound is used for all
%−−−−−−−−−−−−−→dimensions. A vector of length NVAR can be used to specifiy different
%−−−−−−−−−−−−−→lower bounds for each dimension. {Default = -Inf}
% UB = Upper bound of parameters. If scalar, same upper bound is used for all
%−−−−−−−−−−−−−→dimensions. A vector of length NVAR can be used to specifiy different
46 %−−−−−−−−−−−−−→upper bounds for each dimension. {Default = +Inf}
% USEROPTIONS = Structure containing fields to specify settings of the ES
%−−−−−−−−−−−−−→algorithm. The following fields can be optionally specified. Values in
%−−−−−−−−−−−−−→curly braces indicate defalut values used.
% MU = Number of parents {7}
51 % LAMBDA = Number of children {50}
% MAXITER = Maximum number of iterations or generations. {50}
% INITSTEP = Determines step size of the first generation using the
% −−−−−−−→ equation STEPSIZE = INITSTEP*(UB-LB)
% LOGSPACE = Solve the problem in log space instead of linear? {false}
56 % ABSTOLSCORE = Absolute tolerance for score: stop if |best -worst| <
% ABSTOLSCORE {1e-3}
% RELTOLSCORE = Relative tolerance for score: stop if |best - worst| <
% RELTOLSCORE*mean(score) {1e-6}
% ABSTOLSTEPSIZE = Absolute tolerance for step size: stop if each step size↓
→ <
61 % ABSTOLSTEPSIZE {1e-3}
% RELTOLSTEPSIZE = Relative tolerance for step size: stop if (step
% size)/(parameter value) < RELTOLSTEPSIZE for each step size {1e-6}
% MAXMUTATIONATTEMPT = Maximum number of attempts to mutate object ↓
→ parameter.
% See function mutate for detailed description. {30}
66 % PARALLEL = Can FITNESSFN evaluate candidates in parallel? Use if ↓
→ FITNESSFN
% is parallelized or a speed up is expected {false}
% FUNEVALLIM = Maximum number of objective function evaluations allowed
% {NVAR*1e4}
% DISPLAY = Show progress in command window {false}
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71 % USEHM = Use the hyper-mutation partial restart strategy? {false}
% ** The following options are meaningful only if USEHM is true **
% HMFREQUENCY = Frequency of occurrence of hypermutants (parameter phi in ↓
→ the
% manuscript). HMFREQUENCY fraction of step-sizes (randomly selected)↓
→ are
% increased by factor HMSTRENGTH {0.4}
76 % HMSTRENGH = Strength of hyper mutation (parameter rho in the manuscript).
% Step-sizes of randomly selected parameters are multiplied by ↓
→ HMSTRENGTH.
% −−−−−−−→ HMSTRENGTH should be greater than 1. {10}
% STAGNATIONGENHISTORY = Number of generations to monitor to determine if
% evolution has stagnated. If the relative percent change in the best↓
→ score is
81 % less than STAGNATIONTHRESHOLD over the last STAGNATIONGENHISTORY
% generations , evolution is assumed to have stagnated. {NVAR}
% STAGNATIONTHRESHOLD = If relative percent difference between scores of
% successive generations is less than STAGNATIONTHRESHOLD for
% −−−−−−−→ STAGNATIONGENHISTORY generations , evolution is assumed to have
86 % stagnated. {1}
% RESTARTLIM = Maximum number of hypermutation rounds allowed. {10}
% RESTARTNOIMPROVELIM = Maximum number of successive restarts withour
% improving the score. If the score does not improve in ↓
→ RESTARTNOIMPROVELIM
% successive restarts, the algorithm stops. {3}
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%% Check validity of the input arguments and update optimization settings
if nargin < 2




if ~isa(fitnessFn , ’function_handle’)




error(’Argument 2 (nvar) should be a scalar’);
end
options = defaultOptions(nvar); %get default options
106
% Check if options specified by user match the allowed names.
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if nargin > 4 %one or more fields of options struct are specified by the ↓
→ user
if ~isstruct(userOptions)
111 error(’Incorrect data type: userOptions should ↓
→ be a structure\n’);
end
names = fieldnames(userOptions);
for i = 1:length(names)
if ~isfield(options, names{i})
116 error(’%s is not a valid option. Check ↓







options.logInit = true; % if search is in log space, initialize ↓
→ generation 0 in log space
end
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if options.hmStrength < 1
warning(’Hyper-mutation strength is less than 1. ↓
→ Values greater than 1 are recommended’);
end
131 % Check the bounds
if nargin > 3 % ub has been passed
if ~isnumeric(ub)
error(’Incorrect data type: ub should be numeric↓
→ ’);
end
136 if isempty(ub) % no limit specified
ub = ones(1, nvar)*Inf; % set to +inf
elseif length(ub) == 1 % one number specied. Use this ub for all ↓
→ params
ub = ub*ones(1, nvar);
elseif length(ub) ~= nvar
141 error(’Vector size mismatch: ub should be a ↓
→ scalar or a vector of length nvar’);
end
else %ub not specified




if nargin > 2 %lb has been passed
if ~isnumeric(lb)
error(’Incorrect data type: lb should be numeric↓
→ ’);
end
151 if isempty(lb) % no limit specified
lb = -ones(1, nvar)*Inf; % set to -inf
elseif length(lb) == 1 % one number specied. Use this lb for all ↓
→ params
lb = lb*ones(1, nvar);
elseif length(lb) ~= nvar
156 error(’Vector size mismatch: lb should be a ↓
→ scalar or a vector of length nvar’);
end
else %lb not passed
lb = -ones(1, nvar)*Inf; % set to -inf
end
161
if any(ub <= lb)
error(’Error: ub should be greater than lb’);
end
166 % Start ES
%% Initialize data to be used for optimization
[params, stdDev] = ...
gen0(nvar, lb, ub, options.mu, options.logInit, ↓
→ options.logSpace , options.initStep);
[scoreParents , funEvalCount] = scoreVectors(params, ↓
→ fitnessFn , options.parallel, options.logSpace, 1);
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%% Let the system evolve until stopping criteria are met
iter = 1; % iteration or generation number
numRescales = 0; % number of times strategy parameter hypermutation has↓
→ been used
lastRestartTime = -Inf; % iteration number at which the last restart was↓
→ applied.
176 % At the beginning of the run, this time was inf↓
→ generations ago (i.e., no restart yet)
bestScoreBeforeHM = zeros(options.restartLim , 1); % ↓


















bestScores = zeros(options.maxIter, 1); bestScores(1) = ↓
→ min(scoreParents);




if options.display && mod(iter, 1) == 0
fprintf(1, ’Iteration %d, best score = %g, worst↓
→  score = %g\n’, ...
186 iter, min(scoreParents), max(scoreParents));
end
%%% Store the best and worst stores
bestScores(iter) = min(scoreParents);
191 worstScores(iter) = max(scoreParents);
%%% Check if max iteration is reached
if iter > options.maxIter
if options.display





201 if funEvalCount > options.funEvalLim
if options.display
138
fprintf(’Maximum number of objective ↓




%%% If hypermutation is not requested and stopping criteria are met,
%%% exit evolution loop.
stopCriteria = stop(scoreParents , params, stdDev, ↓
→ options.absTolScore , options.relTolScore , options↓
→ .absTolStepSize , options.relTolStepSize , options.↓
→ display);
211 if ~options.useHM && stopCriteria
break;
end
%%% If hypermutation is requested , then rescale the standard deviations
216 %%% if scores are stagnating or stopping criteria are met. Stop if
%%% score is not improving despite several restarts.
if options.useHM && ...
( stopCriteria || (iter - lastRestartTime >=↓
→ options.stagnationGenHistory && ↓
→ scoresStagnant(options, bestScores , iter)↓
→ ) )
% (line above) check for stagnation ↓
→ only if sufficient time has passed ↓
→ since last restart,
221 % otherwise restarts can possibly occur↓
→ too close to each other
% If scores have not improved after several restarts, then stop.
if numRescales > options.restartNoImproveLim
indicesOfLastFew = (numRescales - options.↓
→ restartNoImproveLim):numRescales;
226 if all(diff(bestScoreBeforeHM(↓
→ indicesOfLastFew)) >= 0)
if options.display, fprintf(1, ’Stopping↓






% Introduce HMs or stop if maximum no. of restarts exceeded
139
if numRescales >= options.restartLim %maximum ↓
→ rounds of hypermutation are done
if options.display, fprintf(1, ’Maximum ↓
→ number of restarts reached\n’); end
break;
236 else %not at max rounds of hypermutation
% Rescale
if options.display, fprintf(1, ’Rescaling at↓
→  iteration %d\n’, iter); end
stdDev = hyperMutation(stdDev, options.↓
→ hmFrequency , options.hmStrength);
numRescales = numRescales + 1;
241 lastRestartTime = iter; % update time of latest ↓
→ restart
bestScoreBeforeHM(numRescales) = bestScores(↓





%%% Recombine to produce children
[paramsChild , stdDevChild] = recombine(params, ↓
→ stdDev, options.lambda);
251 %%% Mutation of individuals
[paramsChild , stdDevChild] = ...
mutate(paramsChild , stdDevChild , lb, ub, options↓
→ .maxMutationAttempt);
%%% Scoring the individuals
256 [scoreChildren , funEvalCount] = scoreVectors(↓
→ paramsChild , fitnessFn , options.parallel, options↓
→ .logSpace);
%%% Select the next generation of parents
[params, stdDev, scoreParents] = ...
select(paramsChild , stdDevChild , scoreChildren , ↓
→ options.mu);
261
iter = iter + 1;
end
140
266 %%% Trim the storage vectors if required





optimParamIdx = find(scoreParents == bestScores(end), 1,↓
→ ’first’); %index of the best solution
optimParam = params(optimParamIdx , :); %the best parameter set in↓
→ the last generation





function stopFlag = ...
stop(score, param, stdDev, absTolScore , relTolScore ,↓
→ absTolStepSize , relTolStepSize , out)
281 % Check if the evolving system meets any of the following stopping criteria
% absTolScore = absolute tolerance for score: |best -worst| < absTolScore
% relTolScore = relative tol for score: |b - w| < relTolScore*mean(score)
% absTolStepSize = abs tol for step size: Each step size < absTolStepSize
% relTolStepSize = rel tol for step size: step size/paramValue <
286 % relTolStepSize for each step size
% Display stopping decision if out is true.
stopFlag = false;
best = min(score);
291 worst = max(score);
if abs(worst - best) < absTolScore
stopFlag = true;
if out
296 fprintf(’Absolute tolerance satisfied. Best ↓









fprintf(’Relative tolerance satisfied. Best ↓





if all(all(stdDev < absTolStepSize))
stopFlag = true;
311 if out
fprintf(’Step size absolute tolerance satisfied.↓






if all(all(stdDev./param < relTolStepSize))
stopFlag = true;
if out
fprintf(’Step size relative tolerance satisfied.↓







function [paramsParent , stdDevParent , scoreParent] = ...
select(paramsChild , stdDevChild , scoreChildren , ↓
→ numParents)
% Select the best scoring children and assign them as parents for the next
% generation. Return the scores of the individuals retained
331
[~, idx] = sort(scoreChildren); %get the indices of sorted ↓
→ individuals
paramsParent = paramsChild(idx(1:numParents), :);
stdDevParent = stdDevChild(idx(1:numParents), :);
336 scoreParent = scoreChildren(idx(1:numParents));
%---
142
function [params, stdDev] = mutate(params, stdDev, lb, ↓
→ ub, maxMutationAttempt)
341 % Mutate the strategy parameters (s) and then mutate the object params (x) using
% the following equations:
% s’(k, i) = s(k, i)*exp(tao’*N(0, 1) + tao*Ni(0, 1))
% x’(k, i) = x(k, i) + s’(k, i)*Ni(0, 1)
% k = individual #; i = ith component of the vector
346 % N(0, 1) = for the whole vector; Ni(0, 1) = for each ith component
%
% tao = 1/sqrt(2*sqrt(n))
% tao’ = 1/sqrt(2*n)
%
351 % Ref: Xin Yao, Evolutionary computation (2002). Ch 2 in Evolutionary
% Optimization , R. Sarker, M. Mohammadian , X. Yao (Eds.).
[popSize, numParam] = size(params); %number of individuals and ↓
→ number of parameters per individual
356 %% update the strategy parameters using the expression in function comments
taoIndivid = 1/sqrt(2*sqrt(popSize));
taoCommon = 1/sqrt(2*popSize);
nCommon = randn(popSize, 1); %one common N(0,1) for each ↓
→ individual
nIndivid = randn(popSize, numParam); %individual and ↓
→ parameter specific variate
361 stdDev = stdDev.*exp(bsxfun(@plus, taoCommon*nCommon, ↓
→ taoIndivid*nIndivid));
%% update the optimization parameters
% Element-wise operation is used to mutate each object parameter and check
% if it is within upper and lower bounds. If not, a new mutation is
366 % attempted. This is until a valid number is found. If no value is
% determined in maxMutationAttemp attempts, the previous value is kept.
for j = 1:numParam %traverse along columns
for i = 1:popSize
failCount = 0;
371 while 1
temp = params(i, j) + stdDev(i, j).*randn;
if temp > lb(j) && temp < ub(j) %loop till a ↓
→ number within limits is found
params(i, j) = temp;
break
376 else
failCount = failCount + 1;
143
if failCount > maxMutationAttempt %if an ↓









function [paramsChild , stdDevChild] = recombine(params, ↓
→ stdDev, numChild)
% Recombine the parents to create the next generation of children.
391
[numParent , numParam] = size(params);
paramsChild = zeros(numChild , numParam);
stdDevChild = zeros(numChild , numParam);
396
% Recombine using global uniform recombination
parentIndex = floor(rand(numChild , numParam)*numParent) ↓
→ + 1; %random indices of parents
for i = 1:numParam
paramsChild(:, i) = params(parentIndex(:, i), i);
401 stdDevChild(:, i) = stdDev(parentIndex(:, i), i);
end
%---
function stagnate = scoresStagnant(opt, scoreHistory , ↓
→ iteration)






if iteration > genHistory
temp = scoreHistory(iteration -genHistory:iteration);↓
→ % last genHistory+1 scores
416
144
if all(abs(diff(temp))./temp(1:end-1)*100 < ↓
→ threshold) % if all changes are less than threshold %




function stdDev = hyperMutation(stdDev, hmFrequency , ↓
→ hmStrength)
% A fraction of strategy parameters are randomly chosen based on user
426 % speciied options and are increased in value to produce hypermutants
r = rand(size(stdDev));
r = r < hmFrequency;




436 function [score, funEval] = scoreVectors(params, ↓
→ fitnessFn , parallel, logSpace, reset)
% Calculate the scores of all the individuals in the population using
% fitnessFn. Each row in params represents one individual.
% If fitnessFn is parallelized (parallel = 1), pass the params
% matrix as such, otherwise , evaluate one parameter vector at a time using
441 % parfor.
% Transform back to linear space if the searching in logSpace.
% The reset argument is used to reset the funEvalCount variable. this
% variable keeps track of how many times the objective function has been
% evaluated.
446
if nargin < 5 %if reset is not passed, do not reset funEvalCount
reset = 0;
end
451 persistent funEvalCount; %number of times the scoring function is ↓
→ called




if logSpace %searchin in log space
145
params = 10.^params; % transform objective parameters back to ↓
→ linear space before passing to scoring fn
end




parfor i = 1:length(score)




471 funEvalCount = funEvalCount + size(params, 1); % the ↓
→ scoring function has been called this many times
% Warn if the score vector has NaN or Inf
if any(isnan(score)) || any(isinf(score))
fprintf(1, ’Warning: The score vector contains Inf ↓
→ or NaN\n’);
476 end
funEval = funEvalCount; %copy persistent variable to return value
%---
481 function [params, stdDev] = gen0(nvar, lb, ub, mu, ↓
→ logInit, logSpace, initStep)
% Create an intial population of parents with lower (lb) and upper (ub)
% bounds. The individuals are generated by uniform random sampling in
% linear (if logInit == false) or log (if logInit == true) space.
% See defaultOption fn for meaning of initStep.
486
% replace +/- Inf with real small/large numbers. These bounds are only used
% here and do not apply to rest of the search. Changing Inf to real numbers
% is required because the sampling method used requires calculation of the
% difference between upper and lower bounds, which should be real.
491 index = (lb == Inf); lb(index) = 1e12;
index = (lb == -Inf); lb(index) = -1e12;
index = (ub == Inf); ub(index) = 1e12;
index = (ub == -Inf); ub(index) = -1e12;
496
% transform lb and ub to log10 space and use the limits to sample
if logInit
146
if any(lb <= 0) || any(ub <= 0)
error(’Cannot use log space with non-positive ↓
→ upper or lower bounds’);
501 else
lb = log10(lb); ub = log10(ub);
end
end
506 % Generate initial population
% r = a + rand*(b-a) => sampling b/w a and b
a = zeros(1, nvar); b = zeros(1, nvar);
a(:) = lb(:); b(:) = ub(:); %this preserves the shape of a. We want a,↓
→ b as row vectors
a = repmat(a, mu, 1);
511 b = repmat(b, mu, 1);
params = a + rand(mu, nvar).*(b-a); %each row is one individual↓
→ ; in (0, 1)
% Generate variances of the individuals
stdDev = initStep.*(b-a);
516
if logInit && ~logSpace %change back to linear-space if log initialize ↓





function options = defaultOptions(nvar)
% Populate the options structure of the optimization algo with the
526 % following defaults
% MU = Number of parents {7}
% LAMBDA = Number of children {50}
% MAXITER = Maximum number of iterations or generations. {50}
% INITSTEP = Determines step size of the first generation using the
531 %−−−−−−−−−−−−−→ equation STEPSIZE = INITSTEP*(UB-LB)
% LOGINIT = Sample in the log space (instead of linear) to initialize
% first generation of objective parameters and step sizes. {false}
% LOGSPACE = Solve the problem in log space instead of linear? If LOGSPACE
% is true, LOGINIT is also switched to true. {false}
536 % ABSTOLSCORE = Absolute tolerance for score: stop if |best -worst| <
% ABSTOLSCORE {1e-3}
% RELTOLSCORE = Relative tolerance for score: stop if |best - worst| <
% RELTOLSCORE*mean(score) {1e-6}
147
% ABSTOLSTEPSIZE = Absolute tolerance for step size: stop if each step size <
541 % ABSTOLSTEPSIZE {1e-3}
% RELTOLSTEPSIZE = Relative tolerance for step size: stop if (step
% size)/(parameter value) < RELTOLSTEPSIZE for each step size {1e-6}
% MAXMUTATIONATTEMPT = Maximum number of attempts to mutate object parameter.
% See function mutate for detailed description. {30}
546 % PARALLEL = Can FITNESSFN evaluate candidates in parallel? Use if FITNESSFN
% is parallelized or a speed up is expected {false}
% FUNEVALLIM = Maximum number of objective function evaluations allowed
% {nvar*1e4}
% DISPLAY = Show progress in command window {false}
551 % USEHM = Use the hyper-mutation partial restart strategy? {false}
% ** The following options are meaningful only if USEHM is true **
% HMFREQUENCY = Frequency of occurrence of hypermutants (parameter phi in the
% manuscript). HMFREQUENCY fraction of step-sizes (randomly selected) are
% increased by factor HMSTRENGTH {0.4}
556 % HMSTRENGH = Strength of hyper mutation (parameter rho in the manuscript).
% Step-sizes of randomly selected parameters are multiplied by HMSTRENGTH.
% HMSTRENGTH should be greater than 1. {10}
% STAGNATIONGENHISTORY = Number of generations to monitor to determine if
% evolution has stagnated. If the relative percent change in the best score ↓
→ is
561 % less than STAGNATIONTHRESHOLD over the last STAGNATIONGENHISTORY
% generations , evolution is assumed to have stagnated. {nvar}
% STAGNATIONTHRESHOLD = If relative percent difference between scores of
% successive generations is less than STAGNATIONTHRESHOLD for
%−−−−−−−−−−−−−→STAGNATIONGENHISTORY generations , evolution is assumed to have
566 % stagnated. {1}
% RESTARTLIM = Maximum number of hypermutation rounds allowed. {10}
% RESTARTNOIMPROVELIM = Maximum number of successive restarts withour
% improving the score. If the score does not improve in RESTARTNOIMPROVELIM






















591 options.funEvalLim = nvar*1e4;
options.display = 0;
%---
Listing 1: (ES-HM.m) The ES-Hm algorithm in Matlab
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tion on large scale global optimization,” Nature Inspired Computation and Applica-
tions Laboratory, USTC, China, 2007. 4.2, C.1
[141] Tanner, J. J., Parsons, Z. D., Cummings, A. H., Zhou, H., and Gates, K. S., “Re-
dox regulation of protein tyrosine phosphatases: structural and chemical aspects,”
Antioxidants & Redox Signaling, vol. 15, no. 1, pp. 77–97, 2011. 1.3, 3.1, 3.4
[142] Templeton, D. J., Aye, M.-S., Rady, J., Xu, F., and Cross, J. V., “Purification of
reversibly oxidized proteins (PROP) reveals a redox switch controlling p38 MAP
kinase activity,” PloS One, vol. 5, no. 11, p. e15012, 2010. 2.4
[143] Tonks, N. K., “Redox redux: revisiting PTPs and the control of cell signaling,” Cell,
vol. 121, no. 5, pp. 667–670, 2005. 1.5
161
[144] Tononi, G., Sporns, O., and Edelman, G. M., “A measure for brain complexity:
relating functional segregation and integration in the nervous system,” Proceedings
of the National Academy of Sciences, vol. 91, no. 11, pp. 5033–5037, 1994. 5.1
[145] Tononi, G., Sporns, O., and Edelman, G. M., “Measures of degeneracy and redun-
dancy in biological networks,” Proceedings of the National Academy of Sciences,
vol. 96, no. 6, pp. 3257–3262, 1999. 5.1, 5.3
[146] Turrens, J. F., “Mitochondrial formation of reactive oxygen species,” The Journal
of Physiology, vol. 552, no. 2, pp. 335–344, 2003. 1.2
[147] van Montfort, R. L., Congreve, M., Tisi, D., Carr, R., and Jhoti, H., “Oxidation
state of the active-site cysteine in protein tyrosine phosphatase 1B,” Nature, vol. 423,
no. 6941, pp. 773–777, 2003. 3.1
[148] Vivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A., and Topol, E. J., “Use of
antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of
randomised trials,” The Lancet, vol. 361, no. 9374, pp. 2017–2023, 2003. 1.2
[149] Voit, E. O., Marino, S., and Lall, R., “Challenges for the identification of biological
systems from in vivo time series data,” In Silico Biology, vol. 5, no. 2, pp. 83–92,
2005. 1.2
[150] Wang, D., Moriggl, R., Stravopodis, D., Carpino, N., Marine, J.-C., Teglund,
S., Feng, J., and Ihle, J. N., “A small amphipathic α-helical region is required
for transcriptional activities and proteasome-dependent turnover of the tyrosine-
phosphorylated Stat5,” The EMBO Journal, vol. 19, no. 3, pp. 392–399, 2000. 3.1,
3.4
[151] Watanabe, Y., Suzuki, O., Haruyama, T., and Akaike, T., “Interferon-γ induces re-
active oxygen species and endoplasmic reticulum stress at the hepatic apoptosis,”
Journal of Cellular Biochemistry, vol. 89, no. 2, pp. 244–253, 2003. 1.2, 1.3
[152] Weber, T. J., Shankaran, H., Wiley, H. S., Opresko, L. K., Chrisler, W. B., and
Quesenberry, R. D., “Basic fibroblast growth factor regulates persistent ERK oscil-
lations in premalignant but not malignant JB6 cells,” Journal of Investigative Der-
matology, vol. 130, no. 5, pp. 1444–1456, 2010. 2.3
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